query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3re4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3re4-assembly1.cif.gz_A Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase bound to Toyocamycin.	0.369	246	152	15	260	10	251	2.598E-21	729
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3re4-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3re4-assembly2.cif.gz_B Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase bound to Toyocamycin.	0.368	244	149	15	258	10	246	4.335E-21	720
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxf-assembly1.cif.gz_z	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxf-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State G	0.355	253	153	21	258	6	258	3.175E-20	692
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly4.cif.gz_D Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.369	245	146	15	259	12	243	1.049E-19	686
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly2.cif.gz_B Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.357	246	148	15	260	10	240	9.359E-20	684
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly3.cif.gz_C Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.361	246	146	15	260	12	240	1.750E-19	683
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.354	246	151	15	260	10	244	1.852E-19	672
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1ztf-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1ztf-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase	0.370	233	146	28	259	20	252	3.371E-18	636
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxh-assembly1.cif.gz_z	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxh-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State H2	0.328	277	173	3	260	1	277	3.000E-20	616
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4otp-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4otp-assembly1.cif.gz_A Crystal structure of the catalytic domain of the human RioK1 atypical protein kinase in complex with ADP/Mg2+	0.361	223	121	36	258	1	190	7.705E-17	582
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxd-assembly1.cif.gz_z	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxd-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State F1	0.370	225	125	34	258	25	224	6.496E-17	579
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxe-assembly1.cif.gz_z	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxe-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State F2	0.356	225	137	36	260	1	214	1.286E-16	485
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zv6-assembly1.cif.gz_h	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zv6-assembly1.cif.gz_h Human RIO1(kd)-StHA late pre-40S particle, structural state B (post 18S rRNA cleavage)	0.344	225	136	36	260	1	209	1.761E-15	471
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zar-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zar-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio2 Kinase Complexed With ADP and Manganese Ions	0.233	218	143	42	259	80	266	4.259E-14	471
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zao-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zao-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio2 Kinase Complexed With ATP and Manganese Ions	0.228	219	146	42	260	81	270	2.218E-13	446
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly2.cif.gz_C Human Rio2 kinase structure	0.272	225	149	38	262	73	278	8.430E-14	429
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7vbt-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7vbt-assembly1.cif.gz_B Crystal structure of RIOK2 in complex with CQ211	0.271	225	149	38	262	73	278	4.024E-14	429
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly1.cif.gz_B Human Rio2 kinase structure	0.271	225	147	38	262	67	269	1.329E-13	428
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly2.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly2.cif.gz_D Human Rio2 kinase structure	0.261	225	153	38	262	69	276	7.964E-14	427
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdn-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdn-assembly1.cif.gz_A Rio2 structure	0.278	216	136	38	253	43	231	3.302E-13	419
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly3.cif.gz_E	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly3.cif.gz_E Human RIOK2 bound to inhibitor	0.283	211	138	43	253	84	277	3.917E-13	416
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdo-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdo-assembly2.cif.gz_B Rio2 structure	0.256	224	158	38	261	68	280	8.430E-14	413
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly4.cif.gz_G	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly4.cif.gz_G Human RIOK2 bound to inhibitor	0.274	211	134	43	253	75	259	9.734E-13	411
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly1.cif.gz_A Human Rio2 kinase structure	0.254	225	154	38	262	73	280	2.784E-13	409
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdo-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdo-assembly1.cif.gz_A Rio2 structure	0.260	225	155	38	262	69	278	2.485E-13	409
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7vbt-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7vbt-assembly1.cif.gz_A Crystal structure of RIOK2 in complex with CQ211	0.258	225	156	38	262	77	287	2.630E-13	403
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly5.cif.gz_H	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly5.cif.gz_H Human RIOK2 bound to inhibitor	0.279	218	139	38	255	78	271	1.091E-12	402
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdn-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdn-assembly1.cif.gz_B Rio2 structure	0.283	216	134	38	253	64	251	1.294E-12	400
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly2.cif.gz_F	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly2.cif.gz_F Human RIOK2 bound to inhibitor	0.268	211	142	43	253	83	277	5.511E-13	400
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly4.cif.gz_J	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly4.cif.gz_J Human RIOK2 bound to inhibitor	0.268	211	142	43	253	84	278	5.833E-13	400
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wu0-assembly1.cif.gz_v	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wu0-assembly1.cif.gz_v Cryo-EM structure of a human pre-40S ribosomal subunit - State RRP12-B3	0.282	208	131	38	245	72	255	1.062E-11	371
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6g51-assembly1.cif.gz_v	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6g51-assembly1.cif.gz_v Cryo-EM structure of a late human pre-40S ribosomal subunit - State D	0.265	225	163	38	262	72	294	4.787E-12	349
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fai-assembly1.cif.gz_l	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fai-assembly1.cif.gz_l Structure of a eukaryotic cytoplasmic pre-40S ribosomal subunit	0.220	215	157	42	256	83	284	7.570E-10	312
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gyi-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gyi-assembly1.cif.gz_A Crystal structure of the Rio2 kinase-ADP/Mg2+-phosphoaspartate complex from Chaetomium thermophilum	0.207	250	184	24	256	51	300	3.712E-11	302
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gyg-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gyg-assembly1.cif.gz_A Crystal structure of the Rio2 kinase from Chaetomium thermophilum	0.214	251	182	24	256	43	293	2.878E-10	287
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6eml-assembly1.cif.gz_r	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6eml-assembly1.cif.gz_r Cryo-EM structure of a late pre-40S ribosomal subunit from Saccharomyces cerevisiae	0.235	200	136	42	241	80	258	4.675E-09	281
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6rbd-assembly1.cif.gz_l	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6rbd-assembly1.cif.gz_l State 1 of yeast Tsr1-TAP Rps20-Deltaloop pre-40S particles	0.220	222	158	35	256	65	268	1.991E-09	272
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7szc-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7szc-assembly2.cif.gz_C Crystal Structure Analysis of human PRPK complex with a compound	0.164	223	163	40	262	7	202	2.576E-08	241
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7szc-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7szc-assembly1.cif.gz_A Crystal Structure Analysis of human PRPK complex with a compound	0.170	220	167	43	262	7	208	2.727E-08	228
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6y7c-assembly1.cif.gz_l	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6y7c-assembly1.cif.gz_l Early cytoplasmic yeast pre-40S particle (purified with Tsr1 as bait)	0.224	220	153	31	250	76	273	2.508E-07	211
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8sam-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8sam-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.160	265	191	35	262	202	466	4.689E-07	175
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8sam-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8sam-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.164	264	189	36	262	204	467	3.735E-07	167
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up4-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	0.170	188	136	53	240	7	171	1.012E-05	162
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oav-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oav-assembly1.cif.gz_B Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.	0.133	211	160	50	260	328	513	9.564E-06	160
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8sap-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8sap-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase ThurKC	0.159	262	190	36	262	188	449	2.736E-06	160
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up8-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	0.150	209	174	54	259	10	218	1.639E-06	158
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up7-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	0.150	212	174	58	263	17	228	1.735E-06	156
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yk2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yk2-assembly1.cif.gz_A The complex structure of Rv3197-erythromycin from Mycobacterium tuberculosis	0.150	265	184	4	220	3	267	1.549E-06	155
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m13-assembly1.cif.gz_a	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m13-assembly1.cif.gz_a Crystal structure of Rnase L in complex with Toceranib	0.137	212	167	50	261	332	525	8.063E-06	155
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m12-assembly1.cif.gz_a	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m12-assembly1.cif.gz_a Crystal Structure of Rnase L in complex with SU11652	0.145	211	178	50	260	330	538	6.422E-06	154
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cz2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cz2-assembly1.cif.gz_A The complex structure of MSMEG_1954-ADP from Mycobacterium smegmatis	0.146	248	196	32	262	5	252	1.101E-06	152
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cyr-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cyr-assembly1.cif.gz_A The closed conformation of MSMEG_1954 from Mycobacterium smegmatis	0.136	252	192	40	262	65	316	1.639E-06	151
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kn6-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kn6-assembly2.cif.gz_B Crystal structure of the C-terminal kinase domain of MSK1	0.153	191	146	53	243	7	179	6.252E-05	149
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kn5-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kn5-assembly2.cif.gz_B Crystal structure of the C-terminal kinase domain of msk1 in complex with AMP-PNP	0.153	191	146	53	243	7	179	7.005E-05	147
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oav-assembly1.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oav-assembly1.cif.gz_D Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.	0.137	221	173	41	261	312	513	1.689E-05	147
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4krd-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	0.163	165	120	54	218	7	150	5.271E-05	146
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yk1-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yk1-assembly1.cif.gz_A The complex structure of Rv3197-AMPPNP from Mycobacterium tuberculosis	0.128	296	207	4	241	3	298	1.101E-06	146
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7elw-assembly1.cif.gz_a	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7elw-assembly1.cif.gz_a Crystal structure of RNase L in complex with Myricetin	0.145	201	167	58	258	339	534	9.035E-06	146
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m11-assembly1.cif.gz_b	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m11-assembly1.cif.gz_b Crystal structure of Rnase L in complex with Sunitinib	0.137	213	179	50	262	332	539	1.508E-05	146
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up4-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up4-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	0.145	218	175	58	263	17	234	6.798E-06	143
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oau-assembly1.cif.gz_C-2	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oau-assembly1.cif.gz_C-2 Complete human RNase L in complex with biological activators.	0.128	229	188	35	263	315	531	1.201E-05	141
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pk6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pk6-assembly1.cif.gz_A Human PRPF4B bound to benzothiophene inhibitor 329	0.131	216	178	53	258	18	233	6.798E-06	139
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o1p-assembly2.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o1p-assembly2.cif.gz_D Crystal Structure of RNase L in complex with 2-5A and AMP-PNP	0.142	211	178	52	262	325	532	1.689E-05	139
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cy2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cy2-assembly1.cif.gz_A The open conformation of MSMEG_1954 from Mycobacterium smegmatis	0.123	249	195	40	262	10	258	2.584E-06	138
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fk3-assembly3.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fk3-assembly3.cif.gz_B B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	0.135	214	175	50	263	8	210	5.906E-05	136
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uhn-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	0.145	210	176	54	260	14	223	7.415E-05	135
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pjj-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pjj-assembly1.cif.gz_B Human PRPF4B bound to benzothiophene inhibitor 224	0.132	196	161	53	238	12	207	1.788E-05	135
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kn6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kn6-assembly1.cif.gz_A Crystal structure of the C-terminal kinase domain of MSK1	0.142	215	177	53	259	7	221	2.984E-05	134
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2jd5-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2jd5-assembly1.cif.gz_A Sky1p bound to Npl3p-derived substrate peptide	0.133	208	164	55	244	17	224	3.747E-05	134
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3og7-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3og7-assembly2.cif.gz_B B-Raf Kinase V600E oncogenic mutant in complex with PLX4032	0.135	214	174	50	263	7	208	8.795E-05	133
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmd-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.139	187	146	58	244	18	187	2.245E-05	133
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8pqb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8pqb-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib derivative 8	0.154	231	172	55	258	25	255	2.377E-05	132
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ian-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ian-assembly1.cif.gz_B Crystal Structure of apo Human PRPF4B kinase domain	0.133	198	160	53	238	10	207	5.271E-05	132
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i35-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i35-assembly1.cif.gz_A Structure of the Human mitochondrial kinase COQ8A R611K with AMPPNP (Cerebellar Ataxia and Ubiquinone Deficiency Through Loss of Unorthodox Kinase Activity)	0.109	259	206	31	262	49	307	2.663E-05	132
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ozy-assembly2.cif.gz_BBB	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ozy-assembly2.cif.gz_BBB FGFR2 kinase domain (residues 461-763) in complex with 38.	0.122	263	184	54	263	16	278	3.344E-05	131
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6agx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6agx-assembly1.cif.gz_A The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.138	224	178	54	260	16	239	3.539E-05	131
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ui0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ui0-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	0.111	255	186	54	263	22	276	4.198E-05	131
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up5-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up5-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	0.136	220	178	53	259	7	226	2.663E-05	130
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7kia-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7kia-assembly2.cif.gz_B Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	0.117	247	185	54	263	16	262	4.444E-05	130
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1mqb-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1mqb-assembly2.cif.gz_B Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase	0.141	203	169	58	260	17	214	3.747E-05	129
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uhn-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uhn-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	0.127	223	180	54	260	14	236	4.979E-05	129
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ped-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ped-assembly1.cif.gz_A Mitochondrial ADCK3 employs an atypical protein kinase-like fold to enable coenzyme Q biosynthes	0.108	265	206	31	262	46	310	3.159E-05	129
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5l4q-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5l4q-assembly2.cif.gz_B Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (AAK1) in Complex with LKB1 (AAK1 Dual Inhibitor)	0.129	201	159	52	252	16	198	2.984E-05	128
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly1.cif.gz_A DISEASE LINKED MUTATION IN FGFR	0.132	230	179	54	260	20	249	4.198E-05	128
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xp7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xp7-assembly1.cif.gz_A C-Src in complex with ATP-CHCl	0.144	203	165	58	260	16	209	1.310E-04	127
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1gjo-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1gjo-assembly1.cif.gz_A The FGFr2 tyrosine kinase domain	0.133	219	179	54	260	16	234	3.966E-05	127
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2psq-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2psq-assembly1.cif.gz_B Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	0.139	223	177	54	260	16	238	5.271E-05	127
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zv9-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zv9-assembly1.cif.gz_A Lyn Tyrosine Kinase Domain-PP2 complex	0.125	206	176	55	260	12	213	4.979E-05	125
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ugl-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.147	209	175	55	260	17	225	1.169E-04	125
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lgs-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lgs-assembly1.cif.gz_A Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.131	263	182	53	262	9	271	6.252E-05	125
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j98-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j98-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Mutation.	0.132	237	179	54	260	22	258	6.618E-05	125
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7elw-assembly1.cif.gz_b	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7elw-assembly1.cif.gz_b Crystal structure of RNase L in complex with Myricetin	0.147	220	187	43	262	312	531	1.072E-05	125
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxo-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxo-assembly2.cif.gz_B human Src kinase bound to kinase inhibitor bosutinib	0.126	203	169	58	260	15	208	1.237E-04	124
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j96-assembly3.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j96-assembly3.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	0.132	233	179	54	260	22	254	4.198E-05	124
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zyl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zyl-assembly1.cif.gz_A Crystal Structure of Hypothetical Protein YihE from Escherichia coli	0.113	262	195	42	262	12	273	1.346E-05	124
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yht-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yht-assembly2.cif.gz_B bRaf complexed with an inhibitor	0.142	214	176	50	263	7	212	4.444E-05	123
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxz-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxz-assembly2.cif.gz_B Src M314L T338M double mutant bound to kinase inhibitor bosutinib	0.130	221	182	54	263	11	231	6.618E-05	123
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j99-assembly5.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j99-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.126	259	180	54	260	17	275	8.795E-05	123
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4w9x-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4w9x-assembly1.cif.gz_A Crystal Structure of BMP-2-inducible kinase in complex with baricitinib	0.161	187	139	58	244	18	184	2.065E-04	123
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uxa-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uxa-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphB from Escherichia coli	0.121	263	193	43	262	7	269	9.564E-06	123
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2dq7-assembly1.cif.gz_X	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2dq7-assembly1.cif.gz_X Crystal Structure of Fyn kinase domain complexed with staurosporine	0.116	210	182	54	260	12	221	2.065E-04	122
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zc6-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zc6-assembly3.cif.gz_C Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor	0.136	226	181	54	263	10	235	3.344E-05	122
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	0.142	224	177	54	260	20	243	9.310E-05	122
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mnf-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mnf-assembly1.cif.gz_B Crystal structure of BRAF-V600E bound to GDC0879	0.131	226	182	54	263	10	235	2.377E-05	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zv8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zv8-assembly1.cif.gz_A Lyn Tyrosine Kinase Domain-AMP-PNP complex	0.116	233	184	55	263	12	244	1.468E-04	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3psd-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3psd-assembly1.cif.gz_A Non-oxime pyrazole based inhibitors of B-Raf kinase	0.148	206	169	58	263	15	213	7.005E-05	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxo-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxo-assembly1.cif.gz_A human Src kinase bound to kinase inhibitor bosutinib	0.126	203	170	58	260	16	210	1.554E-04	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6vnv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6vnv-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 14	0.125	220	183	54	263	10	229	6.618E-05	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8h75-assembly1.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8h75-assembly1.cif.gz_D FGFR2 in complex with YJ001	0.138	217	179	55	263	17	233	1.043E-04	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j95-assembly5.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.142	218	177	54	260	16	233	1.386E-04	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nz0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nz0-assembly1.cif.gz_A Non-phosphorylated TYK2 kinase with CMP6	0.134	229	181	54	263	11	239	9.855E-05	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kxx-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	0.160	218	173	54	260	24	241	2.592E-04	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly4.cif.gz_D DISEASE LINKED MUTATION IN FGFR	0.147	228	176	54	260	15	242	4.979E-05	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ui0-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ui0-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	0.142	237	177	54	260	21	257	1.104E-04	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j96-assembly3.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j96-assembly3.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	0.127	237	180	54	260	21	257	8.795E-05	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv5-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv5-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK9	0.153	206	169	54	259	16	215	1.169E-04	121
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yht-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yht-assembly1.cif.gz_A bRaf complexed with an inhibitor	0.139	214	176	50	263	7	211	6.618E-05	120
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ri1-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ri1-assembly2.cif.gz_B Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	0.119	243	183	55	263	16	258	1.104E-04	120
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pwl-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	0.138	224	177	55	260	16	239	1.169E-04	120
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7b7s-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7b7s-assembly1.cif.gz_A CDK2/cyclin A2 in complex with 3H-pyrazolo[4,3-f]quinoline-based derivative HSD1368	0.176	167	119	52	218	1	145	6.086E-04	120
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kbq-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	0.162	224	181	44	260	2	225	1.468E-04	120
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u6a-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u6a-assembly1.cif.gz_A Crystal structure of Yck2 from Candida albicans in complex with kinase inhibitor GW461484A	0.155	228	177	53	262	6	233	3.075E-04	120
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4hvd-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4hvd-assembly1.cif.gz_A JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((S)-1,2,2-trimethyl-propyl)-amide	0.137	226	180	54	263	9	234	1.310E-04	119
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0o-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0o-assembly1.cif.gz_A Structure of P. falciparum PfPK5-Indirubin-5-sulphonate ligand complex	0.157	201	167	55	255	2	200	7.005E-05	119
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gvj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gvj-assembly1.cif.gz_A Tyk2 (JH1) in complex with adenosine di-phosphate	0.137	256	180	54	263	10	265	1.554E-04	119
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmc-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.150	183	153	58	240	18	198	2.984E-05	119
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv8-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E63	0.154	206	170	54	259	17	218	3.445E-04	119
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6yu1-assembly2.cif.gz_c	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6yu1-assembly2.cif.gz_c CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	0.125	207	165	53	242	30	236	5.131E-04	119
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly1.cif.gz_H-2	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly1.cif.gz_H-2 ROCK2 IN COMPLEX WITH COMPOUND 12	0.132	237	203	26	260	25	261	1.237E-04	119
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7udp-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7udp-assembly1.cif.gz_A Crystal structure of COQ8A-CA157 inhibitor complex in space group C2	0.141	254	189	42	262	49	302	8.309E-05	119
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c2y-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c2y-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257142	0.157	220	176	54	263	163	382	9.855E-05	119
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2psq-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2psq-assembly1.cif.gz_A Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	0.142	225	176	55	260	16	240	1.386E-04	118
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4k33-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4k33-assembly1.cif.gz_A Crystal Structure of FGF Receptor 3 (FGFR3) Kinase Domain Harboring the K650E Mutation, a Gain-of-Function Mutation Responsible for Thanatophoric Dysplasia Type II and Spermatocytic Seminoma	0.111	275	184	55	262	16	290	1.310E-04	118
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nr9-assembly1.cif.gz_A-2	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nr9-assembly1.cif.gz_A-2 Structure of human CDC2-like kinase 2 (CLK2)	0.125	207	165	53	242	25	231	4.847E-04	118
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7udq-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7udq-assembly1.cif.gz_A Crystal structure of COQ8A-CA157 inhibitor complex in space group P1	0.122	252	193	42	262	45	296	7.415E-05	118
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wne-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wne-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.114	271	213	19	259	34	304	4.979E-05	118
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wne-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wne-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.117	262	212	19	259	44	305	3.539E-05	118
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4cva-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4cva-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	0.144	209	169	55	263	13	210	2.744E-04	117
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1nd4-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1nd4-assembly1.cif.gz_B Crystal structure of aminoglycoside-3'-phosphotransferase-IIa	0.101	232	197	44	263	5	236	1.741E-04	117
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lgs-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lgs-assembly2.cif.gz_B Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.129	266	182	53	262	9	274	7.849E-05	117
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvi-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvi-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	0.144	198	161	58	255	17	205	9.855E-05	117
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fy0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fy0-assembly1.cif.gz_A Crystal structure of PAK1 kinase domain with ruthenium complex DW1	0.152	228	187	40	260	3	230	1.310E-04	117
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4d2t-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4d2t-assembly4.cif.gz_D Structure of MELK in complex with inhibitors	0.163	208	172	53	260	7	213	4.979E-05	117
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.121	233	197	36	260	43	275	1.645E-04	117
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly1.cif.gz_A ROCK2 IN COMPLEX WITH COMPOUND 12	0.127	254	204	26	260	26	279	1.310E-04	117
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0p-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0p-assembly1.cif.gz_A Structure of P. falciparum PfPK5-Purvalanol B ligand complex	0.177	161	117	52	212	1	143	3.255E-04	116
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rj8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rj8-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-(DIFLUOROM ETHOXY)-4-(1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	0.130	185	158	58	240	19	203	7.005E-05	116
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ugx-assembly2.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ugx-assembly2.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	0.136	237	178	54	260	15	251	2.186E-04	116
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wne-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wne-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.134	252	210	19	262	43	294	8.535E-06	116
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7udq-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7udq-assembly2.cif.gz_B Crystal structure of COQ8A-CA157 inhibitor complex in space group P1	0.117	256	195	42	263	51	306	1.951E-04	116
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly4.cif.gz_G-5	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly4.cif.gz_G-5 ROCK2 IN COMPLEX WITH COMPOUND 12	0.126	256	205	26	260	25	280	2.314E-04	116
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l7s-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l7s-assembly1.cif.gz_A Kinase domain mutant of human Itk in complex with an aminobenzothiazole inhibitor	0.133	207	167	54	260	10	203	1.310E-04	115
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2z2w-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2z2w-assembly1.cif.gz_A Human Wee1 kinase complexed with inhibitor PF0335770	0.099	242	189	53	263	7	248	1.104E-04	115
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ntt-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ntt-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) C604Y mutant in complex with NMS-P715	0.139	213	179	55	263	17	229	7.005E-05	115
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fy2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fy2-assembly1.cif.gz_A Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYEFIW	0.136	210	179	47	256	12	219	9.310E-05	115
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fxx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fxx-assembly1.cif.gz_A Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYE[pTyr]IW	0.123	210	182	47	256	13	221	8.309E-05	115
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7w19-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7w19-assembly2.cif.gz_B Crystal Structure of Acinetobacter baumannii MPH-E	0.120	261	196	39	262	3	263	2.121E-05	115
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ax8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ax8-assembly1.cif.gz_A Medium resolution structure of the bifunctional kinase- methyltransferase WbdD	0.133	195	163	67	261	238	426	2.314E-04	115
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7kx8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7kx8-assembly1.cif.gz_A Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	0.150	207	166	54	260	10	205	4.087E-04	114
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3en4-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3en4-assembly2.cif.gz_B Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP121, a multitargeted kinase inhibitor	0.105	203	174	58	260	16	210	1.843E-04	114
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mcv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mcv-assembly1.cif.gz_A Star 12 bound to analog-sensitive Src kinase	0.128	203	169	58	260	17	211	1.741E-04	114
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7dua-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7dua-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with 4-amino-7-(1-methylcyclopropyl)-N-(5-methyl-1H-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide	0.127	268	194	40	262	4	271	7.005E-05	114
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvh-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvh-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	0.142	183	148	58	240	17	190	1.951E-04	114
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7w1a-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7w1a-assembly1.cif.gz_B Crystal Structure of MPH-E in complex with GMP and Azithromycin	0.117	258	197	39	262	4	261	2.663E-05	114
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmd-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmd-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.138	215	178	49	255	4	218	6.252E-05	114
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2hel-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2hel-assembly1.cif.gz_A Crystal structure of a mutant EphA4 kinase domain (Y742A)	0.136	211	175	53	263	7	210	1.645E-04	113
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3geq-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3geq-assembly2.cif.gz_B Structural basis for the chemical rescue of Src kinase activity	0.123	203	168	58	260	25	217	3.647E-04	113
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gk4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gk4-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 90	0.123	214	182	47	260	10	218	7.005E-05	113
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly3.cif.gz_C DISEASE LINKED MUTATION IN FGFR	0.141	219	176	55	260	17	235	1.843E-04	113
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3q53-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3q53-assembly1.cif.gz_A Structure of phosphorylated PAK1 kinase domain in complex with ATP	0.157	226	184	40	258	2	227	6.442E-04	113
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4y12-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4y12-assembly1.cif.gz_A Crystal structure of the S/T protein kinase PknG from Mycobacterium tuberculosis in complex with AGS	0.101	258	191	51	263	65	322	2.065E-04	113
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ita-assembly3.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ita-assembly3.cif.gz_A Crystal Structure of BRAF Kinase Domain Bound to AZ-VEM	0.125	214	173	50	263	8	206	2.592E-04	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly2.cif.gz_B Crystal structure of EphB1	0.126	207	167	54	260	10	201	3.255E-04	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2fb8-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2fb8-assembly2.cif.gz_B Structure of the B-Raf kinase domain bound to SB-590885	0.122	206	175	58	263	14	213	1.951E-04	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6oql-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6oql-assembly1.cif.gz_A CDK6 in complex with Cpd13 (R)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl)-N-(5-(4-methylpiperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine	0.136	188	146	54	241	4	173	3.075E-04	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kul-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kul-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 8 (EPHA8)	0.129	210	179	55	260	11	220	8.795E-05	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8tuc-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8tuc-assembly1.cif.gz_A Unphosphorylated CaMKK2 in complex with CC-8977	0.161	250	173	55	261	9	258	7.415E-05	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvh-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	0.139	212	176	50	261	7	211	1.169E-04	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7b7s-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7b7s-assembly2.cif.gz_C CDK2/cyclin A2 in complex with 3H-pyrazolo[4,3-f]quinoline-based derivative HSD1368	0.165	167	121	52	218	1	146	1.695E-03	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly1.cif.gz_A CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.134	232	194	36	260	41	272	3.861E-04	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly2.cif.gz_C-3	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly2.cif.gz_C-3 ROCK2 IN COMPLEX WITH COMPOUND 12	0.141	248	201	26	260	27	274	2.592E-04	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH COMPOUND 12	0.116	252	207	26	260	25	276	1.237E-04	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jou-assembly1.cif.gz_A-2	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jou-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK1) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.125	179	142	40	218	52	214	8.562E-04	112
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgy-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgy-assembly2.cif.gz_B Crystal structure of ITK inhibitor complex	0.145	206	164	55	260	10	202	2.905E-04	111
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5l2t-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5l2t-assembly1.cif.gz_A The X-ray co-crystal structure of human CDK6 and Ribociclib.	0.143	188	143	54	241	4	171	4.087E-04	111
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6eas-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6eas-assembly1.cif.gz_A Co-crystal of pseudokinase DRIK1 (drought responsive inactive kinase 1) bound to ENMD-2076	0.100	249	195	45	262	11	259	1.169E-04	111
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6h-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6h-assembly1.cif.gz_A Src Thr338Ile inhibited in the DFG-Asp-Out conformation	0.123	209	175	55	263	12	212	1.645E-04	111
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x2k-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x2k-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.128	284	192	42	262	3	286	2.186E-04	111
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yhv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yhv-assembly1.cif.gz_A Crystal Structure of PAK1 kinase domain with two point mutations (K299R, T423E)	0.157	228	185	40	260	3	230	2.744E-04	111
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pnx-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pnx-assembly1.cif.gz_B Crystal Structure of an Asymmetric Dimer of FGF Receptor 3 Kinases Trapped in A-loop Tyrosine Transphosphorylation Reaction	0.143	228	176	55	260	20	247	1.310E-04	111
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pjj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pjj-assembly1.cif.gz_A Human PRPF4B bound to benzothiophene inhibitor 224	0.125	194	158	60	241	9	202	1.169E-04	111
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ax3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ax3-assembly1.cif.gz_A Crystal structure of ERK2 complexed with allosteric and ATP-competitive inhibitors.	0.140	191	159	54	244	15	200	5.749E-04	111
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ytw-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ytw-assembly2.cif.gz_B CLK3 bound with benzothiazole Tg003 (Cpd 2)	0.136	205	163	53	242	21	225	2.744E-04	111
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fk3-assembly2.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fk3-assembly2.cif.gz_A B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	0.121	209	171	55	263	12	207	8.795E-05	110
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cpy-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cpy-assembly2.cif.gz_B Structure of apo GRMZM2G135359 pseudokinase	0.105	247	192	47	262	12	258	1.741E-04	110
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mcv-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mcv-assembly2.cif.gz_B Star 12 bound to analog-sensitive Src kinase	0.137	203	167	58	260	16	209	2.314E-04	110
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6lvl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6lvl-assembly1.cif.gz_A Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	0.105	267	184	54	260	15	281	1.237E-04	110
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qkw-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qkw-assembly1.cif.gz_B Structural basis for activation of plant immunity by bacterial effector protein AvrPto	0.165	160	118	59	218	18	159	1.275E-03	110
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv1-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv1-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK4	0.149	165	127	54	218	14	163	8.562E-04	110
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ytw-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ytw-assembly1.cif.gz_A CLK3 bound with benzothiazole Tg003 (Cpd 2)	0.114	206	167	53	242	30	235	5.431E-04	110
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ofv-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ofv-assembly1.cif.gz_B crystal structure of aminoquinazoline 1 bound to Lck	0.141	209	178	55	263	16	223	2.744E-04	109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x9e-assembly1.cif.gz_A-2	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x9e-assembly1.cif.gz_A-2 HUMAN MPS1 IN COMPLEX WITH NMS-P715	0.139	228	180	52	261	6	233	1.043E-04	109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zva-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zva-assembly1.cif.gz_A Lyn Tyrosine Kinase Domain-Dasatinib complex	0.117	206	181	55	260	12	217	1.951E-04	109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2oiq-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2oiq-assembly2.cif.gz_B Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.	0.131	206	170	58	263	15	211	2.905E-04	109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dqx-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dqx-assembly2.cif.gz_B chicken c-Src kinase domain in complex with ATPgS	0.138	203	171	58	260	14	212	2.314E-04	109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ad6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ad6-assembly1.cif.gz_A Crystal structure of Pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)	0.108	252	185	55	262	18	269	2.065E-04	109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6vny-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6vny-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 10	0.143	225	176	55	260	11	235	1.169E-04	109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6v6q-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6v6q-assembly1.cif.gz_B Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.122	228	181	54	260	16	243	1.310E-04	109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8x5z-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8x5z-assembly1.cif.gz_A The Crystal Structure of PAK1 kinase domain from Biortus.	0.154	223	184	40	258	3	225	5.431E-04	109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7q52-assembly1.cif.gz_AAA	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7q52-assembly1.cif.gz_AAA Crystal structure of S/T protein kinase PknG from Mycobacterium tuberculosis in complex with inhibitor L2W	0.115	258	188	51	263	55	312	7.849E-05	109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xlo-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xlo-assembly1.cif.gz_A Crystal structure of bRaf in complex with inhibitor	0.142	206	170	58	263	14	212	8.309E-05	108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5vam-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5vam-assembly2.cif.gz_B BRAF in Complex with RAF709	0.145	214	176	50	263	7	213	3.861E-04	108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6e6e-assembly8.cif.gz_H	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6e6e-assembly8.cif.gz_H DGY-06-116, a novel and selective covalent inhibitor of SRC kinase	0.144	206	167	58	263	15	210	9.594E-04	108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ivv-assembly1.cif.gz_A-2	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ivv-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor PP1	0.137	278	192	40	262	4	281	4.087E-04	108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qoc-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	0.123	206	178	53	256	7	212	1.843E-04	108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7qhl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7qhl-assembly1.cif.gz_A Crystal structure of Cyclin-dependent kinase 2/cyclin A in complex with 3,5,7-Substituted pyrazolo[4,3-d]pyrimidine inhibitor 24	0.157	167	119	52	218	1	142	1.899E-03	108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ikw-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ikw-assembly1.cif.gz_A Crystal Structure of BMP-2-inducible kinase in complex with an Indazole inhibitor	0.144	182	154	58	238	15	196	1.951E-04	108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv9-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv9-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E71	0.139	203	166	57	259	22	215	3.861E-04	108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5hvu-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5hvu-assembly1.cif.gz_B Rho-associated protein kinase 1 (ROCK 1) in complex with a pyridine thiazole piperidine inhibitor	0.129	267	209	19	259	43	309	1.741E-04	108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgw-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgw-assembly2.cif.gz_B Crystal Structure of ITK kinase bound to an inhibitor	0.147	206	161	55	260	8	197	3.445E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pp9-assembly3.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pp9-assembly3.cif.gz_B ITK kinase domain with compound 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-2H-INDAZOLE-3-CARBOXAMIDE)	0.120	235	182	55	262	10	244	7.849E-05	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2og8-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2og8-assembly2.cif.gz_B crystal structure of aminoquinazoline 36 bound to Lck	0.150	206	163	55	260	12	204	3.647E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bi0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bi0-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	0.152	223	175	55	261	12	234	2.592E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dbq-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dbq-assembly1.cif.gz_A Crystal structure of TTK kinase domain	0.125	231	182	55	263	13	243	9.310E-05	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4g9r-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4g9r-assembly2.cif.gz_B B-Raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor	0.128	206	174	58	263	15	214	2.744E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6n0p-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6n0p-assembly1.cif.gz_A BRAF in complex with N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (LXH254)	0.131	208	178	58	263	14	221	3.445E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8g6z-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8g6z-assembly1.cif.gz_A JAK2 crystal structure in complex with Compound 13	0.151	226	175	54	260	8	233	4.579E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2py3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2py3-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	0.117	259	175	62	260	17	275	2.905E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpw-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpw-assembly1.cif.gz_A Crystal structure of the apo-BRI1 kinase domain (865-1160)	0.128	178	136	41	218	9	165	5.131E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7w1a-assembly2.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7w1a-assembly2.cif.gz_A Crystal Structure of MPH-E in complex with GMP and Azithromycin	0.114	258	198	39	262	4	261	2.984E-05	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x2m-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x2m-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.141	260	204	25	263	4	263	2.314E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3niz-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3niz-assembly1.cif.gz_A Cryptosporidium parvum cyclin-dependent kinase cgd5_2510 with ADP bound.	0.165	204	162	58	261	14	208	1.075E-03	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5te0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5te0-assembly1.cif.gz_A Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with BIBF 1120	0.140	220	182	49	261	7	226	1.951E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bue-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bue-assembly1.cif.gz_A ERK2 complexed with N-benzylpyridone tetrahydroazaindazole	0.163	206	166	54	259	14	212	7.219E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2fys-assembly2.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2fys-assembly2.cif.gz_A Crystal structure of Erk2 complex with KIM peptide derived from MKP3	0.144	217	175	54	259	15	231	5.131E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly3.cif.gz_E-4	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly3.cif.gz_E-4 ROCK2 IN COMPLEX WITH COMPOUND 12	0.115	254	207	26	260	27	280	2.449E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly4.cif.gz_G	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly4.cif.gz_G CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.130	241	195	36	260	43	283	4.087E-04	107
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pp9-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pp9-assembly1.cif.gz_A ITK kinase domain with compound 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-2H-INDAZOLE-3-CARBOXAMIDE)	0.141	206	163	55	260	10	200	1.386E-04	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3my0-assembly10.cif.gz_J	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3my0-assembly10.cif.gz_J Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	0.127	207	169	55	261	5	199	5.749E-04	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2in6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2in6-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD311839	0.125	244	200	35	263	2	245	5.579E-05	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6wiw-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6wiw-assembly1.cif.gz_B c-Src Bound to ATP-Competitive Inhibitor I14	0.112	203	170	58	260	14	206	6.819E-04	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5fm3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5fm3-assembly1.cif.gz_A Crystal structure of hyper-phosphorylated RET kinase domain with (proximal) juxtamembrane segment	0.132	260	181	54	262	19	278	2.449E-04	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8g6z-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8g6z-assembly1.cif.gz_B JAK2 crystal structure in complex with Compound 13	0.155	225	174	54	260	8	232	4.087E-04	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oth-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oth-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Ro-31-8220	0.132	211	164	53	263	8	197	1.601E-03	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly2.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.132	225	191	36	260	41	261	3.861E-04	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly2.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.123	260	208	26	263	25	284	1.386E-04	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly4.cif.gz_F	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly4.cif.gz_F ROCK2 IN COMPLEX WITH COMPOUND 12	0.120	255	206	26	260	25	279	2.744E-04	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.131	238	195	36	260	43	280	3.255E-04	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bml-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bml-assembly1.cif.gz_B ROCK 1 bound to a pyridine thiazole inhibitor	0.124	271	210	19	259	43	313	2.314E-04	106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gfw-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gfw-assembly1.cif.gz_A Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrolo-pyridin ligand	0.122	222	182	54	261	12	233	1.386E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly2.cif.gz_B C-Src in complex with ibrutinib	0.122	203	167	58	260	10	200	3.861E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7shv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7shv-assembly1.cif.gz_A Crystal structure of BRAF kinase domain bound to GDC0879	0.157	206	169	58	263	14	214	1.386E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly5.cif.gz_E	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly5.cif.gz_E Crystal structure of EphB1	0.133	203	168	58	260	14	208	6.442E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6oqo-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6oqo-assembly1.cif.gz_A CDK6 in complex with Cpd24 N-(5-(6-ethyl-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-2-yl)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl)pyrimidin-2-amine	0.150	207	167	54	260	4	201	5.431E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i9v-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i9v-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with AGS	0.140	203	173	58	260	14	215	2.449E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzp-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzp-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome	0.115	244	186	53	263	12	255	3.861E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uys-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uys-assembly1.cif.gz_A Crystal structure of TYK2 kinase domain in complex with compound 16	0.151	222	174	55	260	10	231	4.087E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u2h-assembly1.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u2h-assembly1.cif.gz_D BRAF dimer bound to 14-3-3	0.111	259	187	50	260	8	266	4.326E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uxb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uxb-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	0.096	254	195	43	259	4	257	3.647E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5dew-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	0.119	275	196	40	263	2	276	1.237E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uy3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uy3-assembly1.cif.gz_A Crystal structure of human Fgr tyrosine kinase in complex with TL02-59	0.130	204	176	58	260	129	332	9.594E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4w7p-assembly3.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4w7p-assembly3.cif.gz_D Crystal Structure of ROCK 1 bound to YB-15-QD37	0.121	265	211	19	259	42	306	2.744E-04	105
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap5-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap5-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.148	220	176	55	261	13	232	2.186E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3geq-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3geq-assembly1.cif.gz_A Structural basis for the chemical rescue of Src kinase activity	0.099	215	185	58	263	25	239	4.087E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xag-assembly1.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xag-assembly1.cif.gz_D Apo BRAF dimer bound to 14-3-3	0.115	208	181	58	263	12	219	9.594E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvi-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	0.145	198	165	58	255	18	211	2.592E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ih0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ih0-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II Y92M mutant - complex with GDP and erythromycin	0.136	264	188	43	261	8	271	1.508E-05	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6yu1-assembly1.cif.gz_a	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6yu1-assembly1.cif.gz_a CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	0.119	207	167	53	242	20	226	9.063E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ed6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ed6-assembly1.cif.gz_A Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor	0.116	240	198	36	260	39	278	3.647E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uzj-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uzj-assembly1.cif.gz_B Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	0.129	265	209	19	259	43	307	2.186E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnh-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnh-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.097	269	204	33	259	37	305	2.905E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kks-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kks-assembly1.cif.gz_B ROCK 1 bound to azaindole thiazole inhibitor	0.133	272	212	19	263	43	314	1.843E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5he2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5he2-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224406	0.153	263	191	36	261	140	402	4.326E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7mxb-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7mxb-assembly2.cif.gz_B Crystal structure of the S/T protein kinase PknG from Corynebacterium glutamicum in complex with AMP-PNP	0.144	196	161	50	245	46	234	4.087E-04	104
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5na0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5na0-assembly1.cif.gz_A TTK kinase domain in complex with a PEG-linked pyrimido-indolizine	0.172	203	159	54	256	11	203	1.205E-03	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly4.cif.gz_D C-Src in complex with ibrutinib	0.115	203	167	58	260	11	200	2.314E-04	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7shv-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7shv-assembly1.cif.gz_B Crystal structure of BRAF kinase domain bound to GDC0879	0.181	214	170	50	263	7	215	2.314E-04	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ljj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ljj-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) in complex with Reversine	0.144	232	177	54	261	12	243	4.326E-04	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f6x-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f6x-assembly3.cif.gz_C c-Src kinase domain in complex with small molecule inhibitor	0.131	206	151	58	263	18	192	2.065E-04	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6yi8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6yi8-assembly1.cif.gz_A HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	0.132	212	178	55	260	17	228	1.554E-04	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2py3-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2py3-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	0.135	221	177	55	260	16	236	6.819E-04	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3lxp-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3lxp-assembly1.cif.gz_A Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6	0.129	251	182	54	263	11	261	3.255E-04	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1xo2-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1xo2-assembly1.cif.gz_B Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin	0.158	219	173	54	260	2	220	1.205E-03	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5qin-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5qin-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN IN COMPLEX WITH N- {4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2- YL]PYRIDIN-2-YL}ACETAMIDE	0.129	202	172	54	255	6	203	8.088E-04	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fd3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fd3-assembly1.cif.gz_A Thiophosphorylated PAK3 kinase domain	0.117	277	201	35	263	2	278	2.314E-04	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kkt-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kkt-assembly1.cif.gz_B ROCK 1 bound to azaindole thiazole piperazine inhibitor	0.130	271	209	19	259	43	313	2.592E-04	103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4knb-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4knb-assembly4.cif.gz_D C-Met in complex with OSI ligand	0.120	221	178	58	260	20	240	1.554E-04	102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2bdf-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2bdf-assembly2.cif.gz_B Src kinase in complex with inhibitor AP23451	0.131	203	170	58	260	18	214	1.512E-03	102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6in0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6in0-assembly1.cif.gz_A Crystal structure of EphA3 in complex with 18-Crown-6	0.128	214	181	47	260	6	213	2.744E-04	102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gk3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gk3-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 87	0.137	214	179	47	260	10	217	1.468E-04	102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gql-assembly4.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gql-assembly4.cif.gz_B Crystal Structure of activated receptor tyrosine kinase in complex with substrates	0.120	251	181	54	260	17	267	5.749E-04	102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dls-assembly7.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dls-assembly7.cif.gz_C Crystal structure of human PAS kinase bound to ADP	0.144	239	180	53	263	16	254	5.749E-04	102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpz-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpz-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1196) in complex with ADP from Arabidopsis thaliana	0.114	257	197	41	263	9	265	3.445E-04	102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rj7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rj7-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND 2-(1-AMINO-3-METHYLBUTYL)-6- (PYRIDIN-4-YL)QUINOLINE-4-CARBONITRILE	0.141	201	170	55	255	23	221	2.592E-04	102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ed6-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ed6-assembly2.cif.gz_B Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor	0.121	226	197	36	260	38	263	4.326E-04	102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly3.cif.gz_E	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.149	257	199	26	260	27	283	3.861E-04	102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2og8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2og8-assembly1.cif.gz_A crystal structure of aminoquinazoline 36 bound to Lck	0.135	209	168	55	263	11	205	6.086E-04	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ehl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ehl-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.136	230	180	55	263	13	242	3.445E-04	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv6-assembly1.cif.gz_A Human B-Raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor	0.150	214	179	50	263	8	219	1.951E-04	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0o-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0o-assembly2.cif.gz_B Structure of P. falciparum PfPK5-Indirubin-5-sulphonate ligand complex	0.137	202	170	55	256	2	199	4.847E-04	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ozy-assembly1.cif.gz_AAA	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ozy-assembly1.cif.gz_AAA FGFR2 kinase domain (residues 461-763) in complex with 38.	0.143	225	177	53	260	13	237	4.579E-04	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmc-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmc-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.147	201	163	49	240	2	202	1.741E-04	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5igw-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5igw-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II - complex with GDP and clarithromycin	0.115	261	193	40	258	6	266	4.444E-05	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6rq4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6rq4-assembly1.cif.gz_A Inhibitor of ERK2	0.145	218	175	54	259	6	223	1.138E-03	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bui-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bui-assembly1.cif.gz_A ERK2 complexed with 2-pyridiyl tetrahydroazaindazole	0.144	208	175	54	259	14	221	1.695E-03	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ke0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ke0-assembly1.cif.gz_A Discovery of 1-1H-Pyrazolo 4,3-c pyridine-6-yl urea Inhibitors of Extracellular Signal Regulated Kinase ERK for the Treatment of Cancers	0.148	163	125	54	216	7	154	1.601E-03	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kkt-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kkt-assembly1.cif.gz_A ROCK 1 bound to azaindole thiazole piperazine inhibitor	0.121	265	196	36	259	44	308	2.744E-04	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bml-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bml-assembly1.cif.gz_A ROCK 1 bound to a pyridine thiazole inhibitor	0.130	269	209	19	259	42	310	5.749E-04	101
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4d2s-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4d2s-assembly1.cif.gz_A Human TTK in complex with a Dyrk1B inhibitor	0.150	216	175	55	261	15	230	7.641E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4r5y-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4r5y-assembly1.cif.gz_A The complex structure of Braf V600E kinase domain with a novel Braf inhibitor	0.132	206	168	58	263	14	207	6.442E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4cv8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4cv8-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	0.140	225	178	54	261	11	235	1.951E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly3.cif.gz_C C-Src in complex with ibrutinib	0.133	206	166	58	263	12	204	5.749E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yvc-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yvc-assembly1.cif.gz_A Structure of CaMKK2 in complex with CKI-012	0.132	233	179	55	261	8	240	2.314E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o6l-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o6l-assembly1.cif.gz_A Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)	0.139	236	180	54	263	12	247	5.131E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap7-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.143	225	177	55	261	19	243	2.592E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2fum-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2fum-assembly1.cif.gz_A Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.129	207	178	53	257	7	213	7.641E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6e6e-assembly6.cif.gz_F	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6e6e-assembly6.cif.gz_F DGY-06-116, a novel and selective covalent inhibitor of SRC kinase	0.142	206	153	58	263	15	193	1.601E-03	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8flh-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8flh-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with an orthosteric inhibitor	0.135	215	182	53	263	9	223	3.861E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hve-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hve-assembly1.cif.gz_A Kinase domain of cSrc in complex with compound 9	0.136	203	168	58	260	17	211	8.088E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly3.cif.gz_C Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.121	217	185	49	260	8	224	2.314E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwc-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwc-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P3	0.144	234	178	55	263	22	255	2.186E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6f7b-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6f7b-assembly1.cif.gz_A Crystal structure of the human Bub1 kinase domain in complex with BAY 1816032	0.116	260	181	55	260	57	316	2.449E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wng-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wng-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.110	250	198	36	259	45	294	8.795E-05	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7r-assembly1.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7r-assembly1.cif.gz_D Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	0.133	183	150	36	218	41	214	1.695E-03	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv7-assembly1.cif.gz_A Human Rho-associated protein kinase 1 (ROCK 1) in COMPLEX WITH RKI1342	0.113	271	211	21	259	39	309	5.131E-04	100
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgy-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgy-assembly1.cif.gz_A Crystal structure of ITK inhibitor complex	0.148	207	163	54	260	10	201	1.350E-03	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2hwo-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2hwo-assembly1.cif.gz_A Crystal structure of Src kinase domain in complex with covalent inhibitor	0.132	204	155	60	263	19	197	5.131E-04	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap3-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.133	223	179	55	261	12	234	2.065E-04	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5v5y-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5v5y-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH MK1775	0.151	215	180	46	258	2	216	1.075E-03	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5p9h-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5p9h-assembly1.cif.gz_A BTK1 COCRYSTALLIZED WITH RN983	0.133	213	179	53	260	6	218	1.075E-03	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzp-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzp-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome	0.141	213	168	65	260	22	234	9.063E-04	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qon-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qon-assembly1.cif.gz_A Human EphA3 kinase and juxtamembrane region, Y596F:Y602F:Y742A triple mutant	0.127	210	175	47	256	14	215	3.445E-04	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpv-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with AMPPNP and Mn from Arabidopsis thaliana	0.141	178	133	41	218	8	163	9.063E-04	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pvy-assembly1.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pvy-assembly1.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome.	0.132	215	172	65	263	28	242	5.431E-04	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4d2w-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4d2w-assembly2.cif.gz_C Structure of MELK in complex with inhibitors	0.155	208	164	53	260	9	203	2.592E-04	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4qpm-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4qpm-assembly1.cif.gz_A Structure of Bub1 kinase domain	0.114	253	182	55	260	51	303	3.861E-04	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7q-assembly6.cif.gz_D-3	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7q-assembly6.cif.gz_D-3 Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	0.142	193	162	26	218	23	212	7.641E-04	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s26-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s26-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G5018	0.129	262	209	19	259	43	304	3.861E-04	99
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bi2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bi2-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	0.126	228	182	55	263	12	239	2.592E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5eho-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5eho-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.144	209	172	55	263	12	213	4.579E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tn9-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tn9-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16	0.138	231	179	55	263	15	245	4.579E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly4.cif.gz_D Crystal structure of EphB1	0.129	206	173	58	263	14	213	3.255E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nki-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nki-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 4b	0.145	231	173	58	260	15	245	2.905E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1qpd-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1qpd-assembly1.cif.gz_A STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS	0.108	232	186	55	263	17	248	1.075E-03	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4g2f-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4g2f-assembly1.cif.gz_A Human EphA3 kinase domain in complex with compound 7	0.141	214	177	47	260	10	216	1.237E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ckx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ckx-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine	0.119	252	183	55	263	7	258	3.445E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4zji-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4zji-assembly3.cif.gz_C PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.161	221	178	40	260	2	214	1.016E-03	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fek-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fek-assembly1.cif.gz_A Oncogenic point mutation of RET receptor tyrosine kinase	0.119	293	196	40	263	4	296	9.063E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tl8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tl8-assembly1.cif.gz_A The AvrPtoB-BAK1 complex reveals two structurally similar kinaseinteracting domains in a single type III effector	0.119	166	130	53	218	20	168	1.075E-03	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sun-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sun-assembly1.cif.gz_A Amicoumacin kinase hAmiN in complex with AMP-PNP, Ca2+ and Ami	0.127	255	191	43	262	12	266	1.645E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnh-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnh-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.104	278	202	33	259	35	312	6.442E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzi-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzi-assembly2.cif.gz_B Crystal Structure of Protein kinase PknG from Mycobacterium tuberculosis in Complex with Tetrahydrobenzothiophene AX20017	0.142	190	159	51	240	71	256	8.562E-04	98
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jt2-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jt2-assembly1.cif.gz_B BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	0.131	214	171	50	263	9	206	3.255E-04	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tnb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tnb-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 41	0.142	222	177	55	261	11	232	3.861E-04	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n87-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n87-assembly1.cif.gz_A TTK kinase domain in complex with NTRC 0066-0	0.127	226	181	54	261	11	236	1.554E-04	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7bjr-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7bjr-assembly1.cif.gz_A Crystal structure of CHK1-10pt-mutant complex with compound 18	0.171	187	146	54	240	6	182	1.794E-03	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3hmp-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3hmp-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain in complex with a quinazolin ligand Compound 4	0.150	234	178	54	263	11	244	6.086E-04	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7n4q-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7n4q-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with compound 45	0.138	208	177	53	260	9	214	6.819E-04	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv6-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv6-assembly2.cif.gz_B Human B-Raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor	0.127	220	186	50	263	8	227	3.445E-04	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kc3-assembly5.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kc3-assembly5.cif.gz_C MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	0.111	224	185	53	261	21	244	6.086E-04	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nk6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nk6-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2d	0.147	207	172	58	260	14	220	4.326E-04	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5cf4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5cf4-assembly1.cif.gz_A CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10-TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE	0.153	227	174	54	260	8	234	1.350E-03	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5l4q-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5l4q-assembly1.cif.gz_A Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (AAK1) in Complex with LKB1 (AAK1 Dual Inhibitor)	0.135	195	158	58	252	19	202	5.431E-04	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5igh-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5igh-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type I	0.116	268	202	34	262	3	270	7.415E-05	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lue-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lue-assembly1.cif.gz_A Crystal Structure of HCK in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (resulting from displacement of SKF86002)	0.115	213	184	55	263	181	393	8.088E-04	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k7z-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k7z-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.176	185	143	36	220	140	314	1.350E-03	97
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wzk-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wzk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-ylmethyl)amino)imidazo[1,2-a]pyrazin-3-yl)benzamide	0.143	233	178	55	263	12	244	6.086E-04	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5vda-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5vda-assembly1.cif.gz_A Crystal structure of human WEE1 kinase domain in complex with RAC-IV-101, a MK1775 analogue	0.148	201	167	53	249	5	205	6.442E-04	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6mzq-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6mzq-assembly2.cif.gz_B TAS-120 in reversible binding mode with FGFR1	0.148	207	167	54	260	18	214	9.594E-04	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jsm-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jsm-assembly1.cif.gz_A BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	0.141	214	178	50	263	11	218	1.237E-04	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cd6-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cd6-assembly4.cif.gz_D Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.160	164	123	55	218	8	155	5.597E-03	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dqw-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dqw-assembly3.cif.gz_C c-Src kinase domain Thr338Ile mutant in complex with ATPgS	0.126	206	177	58	260	15	220	1.350E-03	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8g8x-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8g8x-assembly1.cif.gz_A X-ray co-crystal structure of compound 27 in with complex JAK2	0.153	248	177	54	263	9	256	1.794E-03	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nho-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nho-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	0.123	218	180	54	259	14	231	1.512E-03	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cbl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cbl-assembly1.cif.gz_A Crystal structure of human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide	0.124	237	183	54	263	97	333	9.063E-04	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p5m-assembly6.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p5m-assembly6.cif.gz_B Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent	0.122	258	204	28	260	31	288	2.993E-03	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wot-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wot-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH 1426382-07-1	0.130	244	195	36	260	44	287	6.442E-04	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k7l-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.133	219	181	54	263	163	381	9.594E-04	96
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1snu-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1snu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN	0.125	235	183	54	263	7	241	6.442E-04	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bi1-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bi1-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	0.135	222	179	54	261	11	232	2.905E-04	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly7.cif.gz_G	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly7.cif.gz_G Crystal structure of EphB1	0.118	207	168	54	260	10	200	1.016E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3byu-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3byu-assembly1.cif.gz_A co-crystal structure of Lck and aminopyrimidine reverse amide 23	0.127	235	179	55	260	17	251	9.063E-04	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ax4-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ax4-assembly2.cif.gz_B Human TYK2 pseudokinase domain (575-869) in complex with 5-(4-Fluoro-phenyl)-2-ureido-thiophene-3-carboxylic acid amide.	0.115	215	185	53	262	9	223	1.794E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3b2w-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3b2w-assembly1.cif.gz_A Crystal structure of pyrimidine amide 11 bound to Lck	0.152	208	175	54	260	9	216	1.016E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jxh-assembly6.cif.gz_F	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jxh-assembly6.cif.gz_F HER2 in complex with JBJ-08-178-01	0.164	223	175	54	263	9	231	7.219E-04	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tz8-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tz8-assembly2.cif.gz_B Kinase domain of cSrc in complex with RL104	0.108	208	176	53	260	10	207	1.075E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ybk-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ybk-assembly1.cif.gz_A C-Helix-Out Dasatinib Analog Crystallized with c-Src Kinase	0.136	203	167	58	260	17	210	1.275E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nud-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nud-assembly1.cif.gz_A FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	0.111	244	183	54	260	16	259	4.326E-04	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k0v-assembly1.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k0v-assembly1.cif.gz_D Crystal structure of bRaf in complex with inhibitor GNE-0749	0.157	163	117	50	212	7	146	3.550E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly7.cif.gz_G	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly7.cif.gz_G Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.125	216	183	51	260	10	225	5.431E-04	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u5l-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u5l-assembly1.cif.gz_A Structure of human ULK4 in complex with an inhibitor	0.160	192	139	55	246	8	174	1.794E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ky2-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ky2-assembly2.cif.gz_B Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain	0.172	212	170	55	260	21	232	1.601E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x2m-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x2m-assembly1.cif.gz_B Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.129	275	193	40	262	4	278	1.016E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2gsf-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2gsf-assembly1.cif.gz_A The Human Epha3 Receptor Tyrosine Kinase and Juxtamembrane Region	0.131	210	175	47	256	16	217	5.131E-04	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6z55-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6z55-assembly2.cif.gz_B Crystal structure of CLK3 in complex with macrocycle ODS2004070	0.123	214	166	53	242	27	240	3.978E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2f2u-assembly2.cif.gz_B-3	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2f2u-assembly2.cif.gz_B-3 crystal structure of the Rho-kinase kinase domain	0.128	260	204	26	260	23	282	1.601E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1fmk-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1fmk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC	0.135	206	167	58	263	191	384	1.205E-03	95
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ofv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ofv-assembly1.cif.gz_A crystal structure of aminoquinazoline 1 bound to Lck	0.131	209	180	55	263	17	224	5.431E-04	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kio-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kio-assembly3.cif.gz_C Kinase domain mutant of human Itk in complex with a covalently-binding inhibitor	0.124	236	180	54	260	10	245	1.138E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5fbo-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5fbo-assembly1.cif.gz_A BTK-inhibitor co-structure	0.127	208	174	53	260	9	208	7.219E-04	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3hmo-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3hmo-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain in complex with the inhibitor staurosporine	0.138	205	170	55	259	14	211	7.641E-04	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mne-assembly2.cif.gz_F	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mne-assembly2.cif.gz_F Crystal structure of the BRAF:MEK1 complex	0.141	197	167	67	263	17	211	1.350E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f3t-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f3t-assembly2.cif.gz_B Kinase domain of cSrc in complex with inhibitor RL38 (Type III)	0.142	206	166	58	263	12	205	1.075E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yom-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yom-assembly2.cif.gz_B Crystal structure of Src kinase domain in complex with Purvalanol A	0.099	207	172	54	260	14	205	1.429E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ccf-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ccf-assembly2.cif.gz_B Crystal Structure of the Human CAMKK1A in complex with Hesperadin	0.137	236	178	55	261	8	243	5.431E-04	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ehg-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ehg-assembly1.cif.gz_A B-Raf Kinase Domain in Complex with an Aminopyridimine-based Inhibitor	0.114	223	182	58	263	15	237	1.843E-04	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f6x-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f6x-assembly4.cif.gz_D c-Src kinase domain in complex with small molecule inhibitor	0.114	203	173	58	260	16	211	9.063E-04	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xp5-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xp5-assembly2.cif.gz_B C-Src in complex with ATP-Chf	0.134	206	156	58	263	14	194	9.063E-04	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mne-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mne-assembly1.cif.gz_B Crystal structure of the BRAF:MEK1 complex	0.104	213	182	60	263	10	222	2.128E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3rhx-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3rhx-assembly1.cif.gz_B Crystal structure of the catalytic domain of FGFR1 kinase in complex with ARQ 069	0.119	234	184	54	263	19	252	1.794E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j97-assembly6.cif.gz_D-3	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j97-assembly6.cif.gz_D-3 Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.136	215	168	65	260	25	239	1.075E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f7w-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f7w-assembly1.cif.gz_A Crystal structure of putative fructosamine-3-kinase (YP_290396.1) from THERMOBIFIDA FUSCA YX-ER1 at 1.85 A resolution	0.125	267	192	44	263	7	273	2.186E-04	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4jdk-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4jdk-assembly1.cif.gz_A Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide S peptide substrate	0.106	214	187	49	262	19	228	3.550E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4xrl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4xrl-assembly1.cif.gz_A Crystal structure at room temperature of Erk2 in complex with an inhibitor	0.155	218	173	54	259	14	231	3.978E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4g6o-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4g6o-assembly1.cif.gz_A Crystal Structure of the ERK2	0.139	165	127	54	218	14	161	3.758E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv7-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E94	0.158	165	125	54	218	14	163	2.671E-03	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ce3-assembly2.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ce3-assembly2.cif.gz_D The Yersinia YopO - actin complex with MgADP	0.125	211	172	57	253	25	235	8.562E-04	94
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap4-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.146	226	176	55	261	13	238	8.088E-04	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6b4w-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6b4w-assembly1.cif.gz_A TTK in Complex with Inhibitor	0.131	229	180	54	261	12	240	1.138E-03	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5d12-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5d12-assembly1.cif.gz_A Kinase domain of cSrc in complex with RL40	0.144	206	146	58	263	16	187	4.087E-04	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1mqb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1mqb-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase	0.139	203	167	58	260	14	208	1.275E-03	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzm-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzm-assembly1.cif.gz_A Brutons tyrosine kinase in complex with compound 50.	0.119	211	182	53	260	6	216	1.016E-03	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8x5k-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8x5k-assembly1.cif.gz_A The Crystal Structure of SYK from Biortus.	0.141	218	184	49	263	5	222	2.671E-03	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1jpa-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1jpa-assembly2.cif.gz_B Crystal Structure of unphosphorylated EphB2 receptor tyrosine kinase and juxtamembrane region	0.128	220	182	44	263	13	222	7.219E-04	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly1.cif.gz_A Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.107	214	187	51	260	10	223	5.131E-04	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i9x-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i9x-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with bosutinib (SKI-606)	0.128	206	176	58	260	15	220	1.138E-03	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nkb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nkb-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 4a	0.137	208	174	58	260	14	221	6.442E-04	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0b-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0b-assembly1.cif.gz_A Crystal structure of the t198a mutant of pfpk5	0.178	161	117	52	212	1	143	1.794E-03	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ump-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ump-assembly2.cif.gz_C Structure of MELK in complex with inhibitors	0.158	219	167	42	260	3	201	2.128E-03	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3pg1-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3pg1-assembly1.cif.gz_A MAP kinase LmaMPK10 from Leishmania major (1.95 angs resolution)	0.157	232	180	43	256	9	240	1.645E-04	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ix3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ix3-assembly1.cif.gz_A Crystal structure of a Stt7 homolog from Micromonas algae	0.127	174	142	53	216	19	192	3.169E-03	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wg4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wg4-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257284	0.159	239	188	36	259	139	377	2.010E-03	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u7c-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u7c-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258747	0.137	263	194	36	261	140	402	2.010E-03	93
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bpy-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bpy-assembly2.cif.gz_B Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with BMS-824171 AKA 6-[(3R)-3-(4-tert-bu tylbenzamido)piperidin-1-yl]-2-{[4-(morpholine-4-carbonyl) phenyl]amino}pyridine-3-carboxamide	0.120	238	182	53	260	6	243	8.562E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ah3-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ah3-assembly2.cif.gz_B Kinase domain of cSrc in complex with a pyrazolopyrimidine	0.113	203	161	58	260	17	199	1.016E-03	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4cv9-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4cv9-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	0.113	224	184	54	261	12	235	3.445E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ei2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ei2-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.147	225	176	55	261	12	236	5.431E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ez5-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ez5-assembly1.cif.gz_A CDK6 (monomeric) in complex with inhibitor	0.141	188	143	54	241	4	170	3.169E-03	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly1.cif.gz_A C-Src in complex with ibrutinib	0.123	206	168	58	263	12	204	1.138E-03	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n9s-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n9s-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1161909	0.136	230	179	54	261	11	240	6.086E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jsm-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jsm-assembly2.cif.gz_C BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	0.125	214	178	50	263	11	214	4.579E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5mrb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5mrb-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) in complex with Cpd-5	0.133	236	180	55	263	14	249	3.647E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bq0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bq0-assembly1.cif.gz_A Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with BMS-824171 AKA 6-[(3R)-3-(4-tert-bu tylbenzamido)piperidin-1-yl]-2-{[4-(morpholine-4-carbonyl) phenyl]amino}pyridine-3-carboxamide	0.132	208	179	53	260	12	218	1.075E-03	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5o91-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5o91-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) C604W mutant in complex with Cpd-5	0.123	237	182	55	263	14	250	8.088E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xag-assembly1.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xag-assembly1.cif.gz_C Apo BRAF dimer bound to 14-3-3	0.144	209	177	55	263	11	218	1.275E-03	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6x8e-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6x8e-assembly2.cif.gz_B Crystal structure of JAK2 with Compound 11	0.157	229	176	54	263	8	236	8.562E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpy-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpy-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ATP from Arabidopsis thaliana	0.107	279	198	41	263	8	286	1.794E-03	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cmj-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cmj-assembly2.cif.gz_B Human CAMKK2 with GSK650393	0.144	248	176	55	261	7	254	6.086E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qti-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qti-assembly1.cif.gz_A c-Met Kinase in Complex with NVP-BVU972	0.119	262	189	45	260	10	271	1.275E-03	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6joi-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6joi-assembly1.cif.gz_A Crystal structure of PDGFRA T674I in complex with crenolanib by co-crystallization	0.124	230	181	55	262	27	256	7.641E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5a46-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5a46-assembly2.cif.gz_B FGFR1 in complex with dovitinib	0.116	266	181	55	260	23	288	1.138E-03	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wsq-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wsq-assembly2.cif.gz_B Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with small molecule inhibitor	0.146	223	180	50	261	1	223	6.819E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4otg-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4otg-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Lestaurtinib	0.124	166	132	53	218	9	160	1.108E-02	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ugb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ugb-assembly1.cif.gz_A Crystal structure of rat ERK2 complexed with docking peptide from ISG20	0.124	234	180	54	260	14	247	1.075E-03	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wng-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wng-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.106	260	199	36	259	46	305	2.186E-04	92
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ate-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ate-assembly1.cif.gz_A SRC kinase bound to covalent inhibitor	0.118	206	163	58	263	16	201	1.350E-03	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ehy-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ehy-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.137	229	180	55	263	13	241	3.075E-04	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3el8-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3el8-assembly2.cif.gz_B Crystal structure of c-Src in complex with pyrazolopyrimidine 5	0.098	210	185	58	263	17	226	1.075E-03	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzr-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzr-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide	0.109	214	185	53	261	8	221	1.016E-03	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qlg-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qlg-assembly1.cif.gz_A Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with dasatinib	0.111	212	182	58	263	15	226	9.594E-04	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxx-assembly1.cif.gz_A Human Src A403T mutant bound to kinase inhibitor bosutinib	0.115	222	185	54	263	12	233	1.899E-03	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6q7f-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6q7f-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL18	0.134	203	164	58	260	14	203	4.326E-04	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nvh-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nvh-assembly1.cif.gz_A FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	0.115	251	182	54	260	16	266	7.641E-04	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2q0b-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2q0b-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation Responsible for Pfeiffer Syndrome	0.140	212	168	65	260	23	234	1.601E-03	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1u59-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1u59-assembly1.cif.gz_A Crystal Structure of the ZAP-70 Kinase Domain in Complex with Staurosporine	0.092	260	190	53	262	8	267	1.205E-03	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7mxj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7mxj-assembly1.cif.gz_A Crystal structure of the S/T protein kinase PknG from Corynebacterium glutamicum (residues 130-433) in complex with AMP-PNP, isoform 1	0.115	248	187	51	262	32	279	6.086E-04	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7xaf-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7xaf-assembly1.cif.gz_A The crystal structure of TrkA kinase in complex with 4^6,14-dimethyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-10-oxo-5-oxa-11,14-diaza-1(3,6)-imidazo[1,2-b]pyridazina-4(1,3)-benzenacyclo- tetradecaphan-2-yne-45-carboxamide	0.120	223	182	53	260	11	233	5.131E-04	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1r0p-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1r0p-assembly1.cif.gz_A Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met in complex with the microbial alkaloid K-252a	0.129	268	189	43	260	13	280	1.075E-03	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oh4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oh4-assembly1.cif.gz_A Crystal structure of BRI1 in complex with BKI1	0.105	281	199	41	263	23	303	9.063E-04	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8aoh-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8aoh-assembly1.cif.gz_A Specific covalent inhibitor(18) of ERK2	0.161	168	124	51	218	11	159	7.438E-03	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8agy-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8agy-assembly1.cif.gz_A The Corramycin phosphotransferase in complex with Corramycin	0.116	258	194	43	262	3	260	4.326E-04	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly3.cif.gz_E	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.116	264	197	36	259	43	306	5.131E-04	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yvc-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yvc-assembly1.cif.gz_B ROCK 1 bound to thiazole inhibitor	0.130	271	209	19	259	43	313	1.695E-03	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs2-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs2-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	0.112	216	182	58	263	188	403	1.512E-03	91
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3v8w-assembly3.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3v8w-assembly3.cif.gz_B Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 469	0.117	227	181	55	260	11	237	1.429E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4feu-assembly6.cif.gz_F	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4feu-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.143	214	170	65	263	13	226	1.386E-04	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zew-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zew-assembly2.cif.gz_B Crystal structure of EphB4 in complex with staurosporine	0.127	209	169	55	263	9	203	2.384E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6mny-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6mny-assembly2.cif.gz_B Crystal structure of mouse BTK kinase domain in complex with compound 9a	0.113	248	186	53	263	6	253	1.794E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3mpm-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3mpm-assembly1.cif.gz_A LCK complexed with a pyrazolopyrimidine	0.138	206	176	55	260	10	214	2.993E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wzj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wzj-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrahydro-2H-pyran-4-yl)methyl)amino)imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropylbenzamide	0.147	234	177	55	263	10	243	1.899E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nlb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nlb-assembly1.cif.gz_A Novel kinase profile highlights the temporal basis of context dependent checkpoint pathways to cell death	0.179	167	117	52	218	1	144	5.597E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv4-assembly1.cif.gz_A Human B-Raf Kinase Domain in Complex with an Bromopyridine Benzamide Inhibitor	0.126	214	181	50	263	8	215	1.601E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6brc-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6brc-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)	0.130	238	179	55	261	9	246	1.138E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c1c-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c1c-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37116	0.145	207	173	54	260	17	219	3.758E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6het-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6het-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT055	0.138	203	164	58	260	14	204	5.131E-04	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lqd-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lqd-assembly1.cif.gz_A Structure of Human MPS1 (TTK) covalently bound to RMS-07 inhibitor	0.144	237	177	54	261	12	248	6.442E-04	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m7z-assembly5.cif.gz_E	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m7z-assembly5.cif.gz_E A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.097	243	206	35	263	22	264	1.138E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4trl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4trl-assembly1.cif.gz_A Structure of Ephrin type-A receptor 2	0.121	207	178	58	260	20	226	6.086E-04	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7juz-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7juz-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib	0.114	161	122	54	214	14	152	5.924E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yi6-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yi6-assembly2.cif.gz_B C-term tail segment of human tyrosine kinase (258-533)	0.131	206	163	58	263	15	203	3.550E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cpy-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cpy-assembly1.cif.gz_A Structure of apo GRMZM2G135359 pseudokinase	0.090	255	197	45	262	19	273	3.861E-04	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gc0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gc0-assembly1.cif.gz_A Structure of the CMGC CDK Kinase from Giardia lamblia in complex with AMP	0.118	204	166	58	261	10	198	1.899E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly4.cif.gz_D Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.135	220	177	55	260	13	232	3.075E-04	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uyj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uyj-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B	0.154	253	174	55	261	9	261	6.442E-04	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wbl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wbl-assembly1.cif.gz_A Crystal structure of CDK2 in complex with pyrazolopyrimidine inhibitor	0.144	208	171	52	259	1	201	4.719E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.122	256	196	36	259	43	298	4.087E-04	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vry-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vry-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 4-Amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane	0.111	217	182	58	263	182	398	2.252E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2h8h-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2h8h-assembly1.cif.gz_A Src kinase in complex with a quinazoline inhibitor	0.113	206	179	58	260	188	393	1.601E-03	90
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3k54-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3k54-assembly1.cif.gz_A Structures of human Bruton's tyrosine kinase in active and inactive conformations suggests a mechanism of activation for TEC family kinases.	0.135	208	163	53	260	9	197	1.512E-03	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4h-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4h-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.133	217	179	55	261	12	228	6.086E-04	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4g-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4g-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.161	220	173	55	261	13	232	3.861E-04	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s26-assembly2.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s26-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G5018	0.147	241	177	19	259	42	249	1.016E-03	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7n4r-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7n4r-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with compound 21	0.129	208	177	53	260	8	211	1.601E-03	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7clh-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7clh-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 19	0.135	229	179	54	261	11	239	1.205E-03	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f3w-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f3w-assembly2.cif.gz_B Drug resistant cSrc kinase domain in complex with inhibitor RL45 (Type II)	0.131	206	166	58	263	15	206	3.758E-03	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4js8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4js8-assembly1.cif.gz_A Crystal structure of TTK kinase domain with an inhibitor: 401348	0.119	230	181	55	261	13	242	4.326E-04	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zon-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zon-assembly1.cif.gz_A Human TYK2 pseudokinase domain bound to a kinase inhibitor	0.105	249	185	53	260	11	259	8.088E-04	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly8.cif.gz_H	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly8.cif.gz_H Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.136	212	177	55	260	13	224	8.562E-04	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5f20-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5f20-assembly1.cif.gz_A Structure of TYK2 with inhibitor 4: 3-azanyl-5-(2-methylphenyl)-7-(1-methylpyrazol-3-yl)-1~{H}-pyrazolo[4,3-c]pyridin-4-one	0.119	216	184	51	260	9	224	1.205E-03	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bql-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bql-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with TAE-226	0.156	251	174	55	261	9	259	5.749E-04	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bsd-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bsd-assembly1.cif.gz_A DDR1 bound to Dasatinib	0.128	217	179	55	260	9	225	2.905E-04	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwb-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwb-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P5	0.135	231	180	55	263	22	252	1.601E-03	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l6q-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l6q-assembly1.cif.gz_A ROCK2 in complex with benzoxaborole	0.147	244	191	36	260	39	282	9.063E-04	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p5m-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p5m-assembly1.cif.gz_A Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent	0.128	284	205	28	263	35	318	1.429E-03	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs5-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs5-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	0.111	216	182	58	263	182	397	1.512E-03	89
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5d11-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5d11-assembly1.cif.gz_A Kinase domain of cSrc in complex with RL235	0.132	206	161	58	263	15	200	1.429E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4jt3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4jt3-assembly1.cif.gz_A Crystal Structure of TTK kinase domain with an inhibitor: 400740	0.137	222	178	55	261	13	234	1.205E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tnd-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tnd-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79	0.137	224	178	55	261	12	235	4.579E-04	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nux-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nux-assembly1.cif.gz_A CDK6 (monomeric) in complex with inhibitor	0.153	188	141	54	241	5	172	4.995E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cd6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cd6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.138	240	178	55	261	6	245	1.205E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8bof-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8bof-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 12	0.142	203	161	58	260	14	202	7.219E-04	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ehe-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ehe-assembly1.cif.gz_A B-Raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor	0.152	214	177	50	263	8	217	1.016E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k0v-assembly1.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k0v-assembly1.cif.gz_C Crystal structure of bRaf in complex with inhibitor GNE-0749	0.129	214	184	50	263	8	219	1.512E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zcp-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zcp-assembly1.cif.gz_A SYK Kinase domain in complex with azabenzimidazole inhibitor 2b	0.119	215	189	49	263	5	219	2.524E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hex-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hex-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATMM006	0.134	203	165	58	260	14	204	6.819E-04	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fsr-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fsr-assembly1.cif.gz_A Crystal Structure of the CHK1	0.169	168	116	51	218	3	143	4.995E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap1-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap1-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.126	245	182	55	263	13	257	9.594E-04	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8p7j-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8p7j-assembly1.cif.gz_A Crystal structure of MAP2K6 with a covalent compound GCL96	0.113	210	184	53	260	7	216	3.354E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uy6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uy6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B	0.167	255	172	55	261	9	263	5.431E-04	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wcl-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wcl-assembly2.cif.gz_B Crystal structure of FGFR1 kinase domain with Pemigatinib	0.136	219	181	54	263	24	242	4.211E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fxv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fxv-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	0.153	165	125	54	218	12	160	1.046E-02	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3r63-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3r63-assembly1.cif.gz_A Structure of ERK2 (SPE) mutant (S246E)	0.160	165	125	54	218	14	163	8.823E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7r-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7r-assembly2.cif.gz_C Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	0.108	260	209	26	260	25	284	2.524E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lue-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lue-assembly2.cif.gz_B Crystal Structure of HCK in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (resulting from displacement of SKF86002)	0.111	206	181	58	263	184	388	1.138E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzi-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzi-assembly1.cif.gz_A Crystal Structure of Protein kinase PknG from Mycobacterium tuberculosis in Complex with Tetrahydrobenzothiophene AX20017	0.130	224	184	51	262	73	296	1.205E-03	88
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgw-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgw-assembly1.cif.gz_A Crystal Structure of ITK kinase bound to an inhibitor	0.118	237	183	55	263	8	244	2.384E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3of0-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3of0-assembly2.cif.gz_B crystal structure of the L317I mutant of the chicken c-Src tyrosine kinase domain	0.124	210	162	54	263	12	197	2.384E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3en4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3en4-assembly1.cif.gz_A Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP121, a multitargeted kinase inhibitor	0.127	206	164	58	263	15	203	1.512E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vqu-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vqu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridin-2- yl)amino]benzamide	0.140	226	180	52	261	12	237	7.641E-04	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tz7-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tz7-assembly2.cif.gz_B Kinase domain of cSrc in complex with RL103	0.120	206	150	58	263	16	187	1.138E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8fln-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8fln-assembly1.cif.gz_A Crystal structure of BTK C481S kinase domain in complex with pirtobrutinib	0.120	256	184	53	262	6	261	1.275E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cil-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cil-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 7	0.144	238	178	55	263	13	250	1.205E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly6.cif.gz_F	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly6.cif.gz_F Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.132	218	181	51	260	10	227	8.088E-04	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5f1z-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5f1z-assembly1.cif.gz_A Structure of TYK2 with inhibitor 16: 3-azanyl-5-[(2~{S})-3-methylbutan-2-yl]-7-[1-methyl-5-(2-oxidanylpropan-2-yl)pyrazol-3-yl]-1~{H}-pyrazolo[4,3-c]pyridin-4-one	0.123	226	186	51	263	11	236	1.695E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4rwj-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4rwj-assembly2.cif.gz_B Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)	0.114	254	182	55	260	22	275	2.252E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xd6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xd6-assembly1.cif.gz_A CARK1 phosphorylates ABA receptors	0.104	254	184	58	263	29	282	7.219E-04	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv4-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK7	0.147	206	169	54	259	16	214	5.597E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fuy-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fuy-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK2	0.146	220	182	46	259	3	222	4.995E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4s30-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4s30-assembly1.cif.gz_A ERK2 intrinsically active mutant (I84A)	0.166	163	122	54	216	13	159	8.823E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnf-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnf-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.129	259	197	33	259	36	294	2.905E-04	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnf-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnf-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.106	269	202	33	259	37	305	4.087E-04	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wot-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wot-assembly1.cif.gz_A ROCK2 IN COMPLEX WITH 1426382-07-1	0.112	241	199	36	260	44	284	2.010E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lud-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lud-assembly2.cif.gz_B Crystal Structure of HCK in complex with the fluorescent compound SKF86002	0.106	214	183	58	263	168	381	1.350E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs7-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs7-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	0.120	214	180	58	263	183	396	4.211E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs4-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs4-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	0.112	216	181	58	262	188	403	3.978E-03	87
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4e-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4e-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.142	226	177	55	261	12	237	4.579E-04	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6h3k-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6h3k-assembly1.cif.gz_A Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enables the discovery of the Phase 1 clinical candidate BOS172722.	0.147	226	176	55	261	12	237	1.138E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5eh0-assembly1.cif.gz_A-2	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5eh0-assembly1.cif.gz_A-2 Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.135	233	180	55	263	12	244	5.431E-04	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tz9-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tz9-assembly2.cif.gz_B Kinase domain of cSrc in complex with RL130	0.103	206	170	55	260	13	203	3.550E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6brc-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6brc-assembly2.cif.gz_B Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)	0.133	235	179	55	261	7	241	1.429E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f3u-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f3u-assembly1.cif.gz_A Kinase domain of cSrc in complex with inhibitor RL37 (Type III)	0.118	206	168	58	263	16	207	1.695E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3oez-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3oez-assembly1.cif.gz_A crystal structure of the L317I mutant of the chicken c-Src tyrosine kinase domain complexed with imatinib	0.106	203	169	58	260	16	205	1.794E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap6-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.135	238	181	54	263	11	248	1.138E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4j-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4j-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.149	232	176	54	261	11	242	9.063E-04	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6g-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6g-assembly1.cif.gz_A Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations	0.128	203	167	58	260	17	208	2.671E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzm-assembly2.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzm-assembly2.cif.gz_D Brutons tyrosine kinase in complex with compound 50.	0.125	212	181	53	260	6	217	1.695E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u2g-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u2g-assembly1.cif.gz_B BRAF-MEK complex with AMP-PCP bound to BRAF	0.116	210	184	54	263	8	216	1.275E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vf9-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vf9-assembly1.cif.gz_A Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Thienopyrazolylindole Inhibitor 027	0.126	208	179	58	263	13	220	1.138E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nwz-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nwz-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	0.134	196	166	65	260	28	220	1.205E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2r2p-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2r2p-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 5 (EphA5)	0.150	212	172	58	260	19	230	7.641E-04	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pnx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pnx-assembly1.cif.gz_A Crystal Structure of an Asymmetric Dimer of FGF Receptor 3 Kinases Trapped in A-loop Tyrosine Transphosphorylation Reaction	0.133	226	179	54	260	18	243	3.758E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4e7w-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4e7w-assembly1.cif.gz_A Structure of GSK3 from Ustilago maydis	0.164	164	125	55	218	23	172	1.350E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs3-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs3-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	0.118	203	172	58	260	183	378	6.271E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uy0-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uy0-assembly2.cif.gz_B Crystal structure of human Fgr tyrosine kinase in complex with A-419259	0.131	206	176	58	260	189	394	3.354E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oli-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oli-assembly1.cif.gz_A The pseudokinase/kinase protein from JAK-family member TYK2	0.135	216	183	51	262	272	487	3.978E-03	86
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6n6o-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6n6o-assembly1.cif.gz_A Crystal structure of the human TTK in complex with an inhibitor	0.130	223	180	54	261	12	234	1.429E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cr0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cr0-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD259_809	0.136	255	185	47	261	2	256	3.354E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3jvr-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3jvr-assembly1.cif.gz_A Characterization of the Chk1 allosteric inhibitor binding site	0.162	168	114	51	218	4	140	7.027E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4zeg-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4zeg-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitor	0.125	235	183	54	263	11	245	1.016E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3svv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3svv-assembly1.cif.gz_A Crystal Structure of T338C c-Src covalently bound to vinylsulfonamide-pyrazolopyrimidine 9	0.136	206	165	58	263	16	207	4.211E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5k9i-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5k9i-assembly2.cif.gz_B Crystal structure of c-SRC in complex with a covalent lysine probe	0.121	206	171	58	263	14	208	3.169E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5teh-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5teh-assembly2.cif.gz_B c-Src V281C kinase domain in complex with Rao-IV-156	0.121	206	168	58	263	17	208	3.354E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ff0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ff0-assembly1.cif.gz_A Structure of BTK kinase domain with the second-generation inhibitor tirabrutinib	0.101	216	189	53	263	6	221	1.350E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ng7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ng7-assembly1.cif.gz_A Src kinase bound to eCF506 trapped in inactive conformation	0.108	203	180	58	260	16	218	1.601E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8c12-assembly1.cif.gz_AAA	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8c12-assembly1.cif.gz_AAA Identification of an intermediate activation state of PAK5 reveals a novel mechanism of kinase inhibition.	0.096	272	199	43	263	9	280	1.275E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n1k-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n1k-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-amino-1-(4-fluorophenyl)ethanol	0.132	266	207	22	261	4	269	2.252E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs4-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	0.121	203	171	58	260	182	376	1.695E-03	85
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pqn-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pqn-assembly1.cif.gz_A ITK kinase domain with compound GNE-9822	0.135	206	163	55	260	9	198	2.993E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hve-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hve-assembly2.cif.gz_B Kinase domain of cSrc in complex with compound 9	0.133	206	153	58	263	15	192	1.075E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hm6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hm6-assembly1.cif.gz_A CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PYRIDINYLOXYMETHYL)PYRIDINE INHIBITOR	0.117	243	189	49	263	4	246	2.010E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2c3l-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2c3l-assembly1.cif.gz_A Identification of a buried pocket for potent and selective inhibition of Chk1: prediction and verification	0.121	236	186	51	263	4	239	1.601E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3aln-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3aln-assembly1.cif.gz_A Crystal Structure of human non-phosphorylated MKK4 kinase domain complexed with AMP-PNP	0.125	233	184	52	262	20	252	1.899E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ya5-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ya5-assembly1.cif.gz_A CRYSTAL STRUCTURE OF c-MET IN COMPLEX WITH NOVEL INHIBITOR	0.121	222	191	43	260	6	227	1.695E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6v9c-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6v9c-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with covalent inhibitor	0.110	258	183	54	260	16	273	1.899E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8wsw-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8wsw-assembly4.cif.gz_D The Crystal Structure of LIMK2a from Biortus	0.096	245	182	58	259	7	251	2.128E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uv4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uv4-assembly1.cif.gz_A Crystal Structure of Maize SIRK1 (sucrose-induced receptor kinase 1) kinase domain bound to AMP-PNP	0.118	268	181	58	263	23	290	4.847E-04	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uxb-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uxb-assembly2.cif.gz_B Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	0.104	258	194	43	259	7	264	3.075E-04	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly2.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	0.140	238	193	36	260	42	279	2.384E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4w7p-assembly3.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4w7p-assembly3.cif.gz_A Crystal Structure of ROCK 1 bound to YB-15-QD37	0.125	265	210	19	259	42	306	1.016E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wot-assembly2.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wot-assembly2.cif.gz_D ROCK2 IN COMPLEX WITH 1426382-07-1	0.130	268	197	36	263	43	310	1.138E-03	84
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4i-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4i-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.126	222	180	55	261	12	233	2.128E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zmd-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zmd-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain T686A mutant in complex with SP600125 inhibitor	0.131	227	179	55	261	12	238	1.512E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxx-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxx-assembly2.cif.gz_B Human Src A403T mutant bound to kinase inhibitor bosutinib	0.115	206	152	58	263	15	187	3.758E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cht-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cht-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 30	0.148	236	178	54	263	12	247	1.275E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5vt1-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5vt1-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B bound to a thiadiazinone benzamide inhibitor	0.141	239	177	55	261	8	246	4.995E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	0.125	195	169	66	260	20	213	1.512E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yhf-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yhf-assembly2.cif.gz_B Bruton's tyrosine kinase in complex with a t-butyl cyanoacrylamide inhibitor	0.121	254	182	53	260	11	264	1.794E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7juw-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7juw-assembly1.cif.gz_B Crystal Structure of KSR1:MEK1 in complex with AMP-PNP	0.121	159	120	54	212	14	150	8.823E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ho6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ho6-assembly1.cif.gz_A ScRIPK WT	0.128	250	191	43	262	7	256	4.719E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ov7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ov7-assembly1.cif.gz_A Crystal structure of D1228V c-MET bound by compound 10	0.134	221	184	43	263	12	224	1.601E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tua-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tua-assembly1.cif.gz_A The RYK Pseudokinase Domain	0.094	280	199	42	262	8	287	2.524E-03	83
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6x3n-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6x3n-assembly1.cif.gz_A Co-structure of BTK kinase domain with L-005085737 inhibitor	0.109	208	176	53	260	9	207	8.088E-04	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wyx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wyx-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-2-(cyclohexylamino)nicotinonitrile	0.146	226	176	55	261	12	237	1.899E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7chm-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7chm-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 8	0.140	230	178	54	261	11	240	7.874E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n93-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n93-assembly1.cif.gz_A TTK kinase domain in complex with TC-Mps1-12	0.137	230	179	54	261	11	240	3.169E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c1o-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c1o-assembly2.cif.gz_B FGFR1 kinase domain complexed with FIIN-1	0.118	238	175	62	260	18	255	2.671E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m7z-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m7z-assembly3.cif.gz_C A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.113	197	169	73	263	61	257	4.458E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cd6-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cd6-assembly3.cif.gz_C Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.127	240	180	55	261	7	246	2.384E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2w96-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2w96-assembly1.cif.gz_B Crystal Structure of CDK4 in complex with a D-type cyclin	0.139	197	158	59	255	9	193	1.350E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6aam-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6aam-assembly1.cif.gz_A Crystal structure of TYK2 in complex with peficitinib	0.144	199	166	66	260	19	217	4.719E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u4w-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u4w-assembly1.cif.gz_A Src in complex with DNA-templated macrocyclic inhibitor MC4b	0.144	206	161	58	263	14	202	3.354E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2q0b-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2q0b-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation Responsible for Pfeiffer Syndrome	0.137	217	171	62	260	17	233	3.550E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpb-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ADP from Arabidopsis thaliana	0.140	178	134	41	218	8	164	7.874E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pmi-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pmi-assembly2.cif.gz_C Structure of the Pho85-Pho80 CDK-cyclin Complex of the Phosphate-responsive Signal Transduction Pathway with Bound ATP-gamma-S	0.127	199	168	67	260	9	207	7.874E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7q-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7q-assembly3.cif.gz_C Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	0.149	193	161	26	218	27	216	8.088E-04	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs7-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	0.121	215	180	58	263	188	402	2.828E-03	82
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qlq-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qlq-assembly2.cif.gz_B Crystal structure of SRC kinase domain with covalent inhibitor RL3	0.131	206	138	58	263	16	175	2.524E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7n9g-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7n9g-assembly1.cif.gz_A Crystal structure of the Abl 1b Kinase domain in complex with Dasatinib and Imatinib	0.123	197	161	67	263	24	208	5.924E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6v2u-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6v2u-assembly2.cif.gz_B Crystal structure of the insect cell-expressed WT-BRAF kinase in complex with Dabrafenib	0.134	210	168	54	263	10	204	2.010E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s9f-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s9f-assembly1.cif.gz_A Crystal structure of the kinase domain of Bruton's Tyrosine Kinase bound to dasatinib	0.102	239	187	54	262	12	250	1.046E-02	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6wiw-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6wiw-assembly1.cif.gz_A c-Src Bound to ATP-Competitive Inhibitor I14	0.133	206	162	58	263	14	201	2.828E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4aua-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4aua-assembly1.cif.gz_A Liganded X-ray crystal structure of cyclin dependent kinase 6 (CDK6)	0.135	188	140	54	241	4	166	1.558E-02	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4dgg-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4dgg-assembly2.cif.gz_B c-SRC kinase domain in complex with RM-1-176	0.137	206	146	58	263	17	186	2.828E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s99-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s99-assembly3.cif.gz_C Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	0.109	214	184	53	260	10	223	3.978E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3piy-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3piy-assembly1.cif.gz_A Crystal structure of BTK kinase domain complexed with R406	0.137	208	178	53	260	10	216	3.169E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3h9f-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3h9f-assembly1.cif.gz_A Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrimido-diazepin ligand	0.155	211	177	54	263	12	222	9.886E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bqq-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bqq-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with BI2526	0.151	244	175	55	261	9	252	2.671E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6gvj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6gvj-assembly1.cif.gz_A Human Mps1 kinase domain with ordered activation loop	0.115	240	183	54	261	12	251	2.252E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hew-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hew-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT069	0.141	203	167	58	260	14	208	1.138E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jv1-assembly1.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jv1-assembly1.cif.gz_D Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor APS-9-95-1	0.127	159	119	54	212	15	151	6.638E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4rwi-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4rwi-assembly2.cif.gz_B Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M), apo	0.121	255	181	54	260	19	273	3.169E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4neu-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4neu-assembly1.cif.gz_A X-ray structure of Receptor Interacting Protein 1 (RIP1)kinase domain with a 1-aminoisoquinoline inhibitor	0.169	226	172	53	260	10	235	1.016E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4q5j-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4q5j-assembly1.cif.gz_A Crystal structure of SeMet derivative BRI1 in complex with BKI1	0.125	241	179	58	263	37	277	1.350E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nyb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nyb-assembly1.cif.gz_A Structure of a MAPK pathway complex	0.116	213	181	58	263	74	286	3.550E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs2-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	0.111	216	182	58	263	185	400	6.638E-03	81
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3d7u-assembly2.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3d7u-assembly2.cif.gz_D Structural basis for the recognition of c-Src by its inactivator Csk	0.120	215	172	49	263	8	204	1.241E-02	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o6l-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o6l-assembly2.cif.gz_B Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)	0.124	226	181	54	261	12	237	1.695E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qlf-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qlf-assembly2.cif.gz_B Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with pyrazolopyrimidine 5	0.107	203	167	58	260	15	202	2.252E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zmc-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zmc-assembly1.cif.gz_A Crystal structure of human mitotic checkpoint kinase Mps1 catalytic domain apo form	0.121	236	184	52	261	5	240	2.384E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3en5-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3en5-assembly2.cif.gz_B Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP494, a multitargeted kinase inhibitor	0.119	206	167	58	263	17	207	4.719E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s9a-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s9a-assembly3.cif.gz_C Crystal structure of the TYK2 pseudokinase domain in complex with TAK-279	0.116	215	184	53	261	10	224	3.978E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ei6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ei6-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.152	239	179	52	263	12	250	1.695E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gh2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gh2-assembly1.cif.gz_A Crystal Structure of the CHK1	0.124	247	180	51	256	3	249	3.758E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oh4-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oh4-assembly2.cif.gz_B Crystal structure of BRI1 in complex with BKI1	0.133	277	193	40	263	17	293	1.899E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ybp-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ybp-assembly1.cif.gz_A Crystal structure of FGFR4(V550L) kinase domain with 10z	0.137	219	180	55	263	17	235	2.671E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ybx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ybx-assembly1.cif.gz_A Crystal structure of FGFR4(V550M) kinase domain with 10z	0.144	219	178	55	263	17	235	1.512E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4y85-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4y85-assembly2.cif.gz_B Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	0.106	211	183	58	263	60	270	1.899E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l68-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l68-assembly2.cif.gz_B Structure of the psedudokinase domain of BIR2, an immune regulator of the RLK/Pelle family	0.131	229	189	32	260	33	251	2.524E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3oz6-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3oz6-assembly1.cif.gz_B Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	0.116	231	177	61	261	16	246	1.899E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3byv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3byv-assembly1.cif.gz_A Crystal structure of Toxoplasma gondii specific rhoptry antigen kinase domain	0.117	252	181	54	259	61	312	2.993E-03	80
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1snx-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1snx-assembly2.cif.gz_B CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN	0.103	237	187	54	263	8	244	2.828E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap2-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.125	232	183	54	263	11	242	1.205E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cek-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cek-assembly1.cif.gz_A Crystal structure of human dual specificity protein kinase (TTK)	0.125	231	183	54	263	12	242	1.350E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nad-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nad-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1217389	0.136	227	179	54	261	11	237	2.993E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bqp-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bqp-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with Crenolanib	0.151	237	175	55	261	8	244	1.275E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cja-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cja-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 28	0.140	237	180	54	263	12	248	2.524E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7dt2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7dt2-assembly1.cif.gz_A Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors	0.121	198	172	67	263	24	221	2.524E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o2p-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o2p-assembly1.cif.gz_A Kinase domain of cSrc in complex with a substituted pyrazolopyrimidine	0.136	206	168	58	263	16	211	5.924E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7chn-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7chn-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 9	0.141	239	180	54	263	12	250	1.899E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4rwk-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4rwk-assembly2.cif.gz_B Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)	0.122	255	181	54	260	21	275	4.458E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nk7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nk7-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2a	0.131	206	176	58	260	15	220	2.828E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6jpe-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6jpe-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with irreversible inhibitor 1	0.126	217	182	55	263	18	234	1.601E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5h3q-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5h3q-assembly1.cif.gz_A Crystal Structure of TrkA kinase with ligand	0.118	225	183	53	260	25	249	1.695E-03	79
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6w8i-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6w8i-assembly1.cif.gz_A Ternary complex structure - BTK cIAP compound 15	0.120	245	184	53	262	8	252	4.995E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n7v-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n7v-assembly1.cif.gz_A TTK kinase domain in complex with MPI-0479605	0.145	230	176	55	261	12	241	1.794E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5teh-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5teh-assembly1.cif.gz_A c-Src V281C kinase domain in complex with Rao-IV-156	0.125	206	166	58	263	17	207	2.524E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wf5-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wf5-assembly1.cif.gz_A c-Src in complex with ponatinib	0.118	203	167	58	260	16	205	3.169E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2oiq-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2oiq-assembly1.cif.gz_A Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.	0.117	203	170	58	260	17	209	2.252E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bku-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bku-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B bound to GSK650394	0.143	240	177	55	261	9	248	2.384E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly11.cif.gz_K	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly11.cif.gz_K Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.125	210	179	55	260	11	220	4.211E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5zj6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5zj6-assembly1.cif.gz_A Crystal structure of HCK kinase complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	0.125	208	179	58	263	20	227	1.391E-02	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4qqt-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4qqt-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Tyrosine Kinase Domain	0.135	224	180	55	263	16	239	8.335E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xi8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xi8-assembly1.cif.gz_A Yeast TFIIK (Kin28/Ccl1/Tfb3) Complex	0.170	208	166	54	261	3	203	4.211E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4q5j-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4q5j-assembly2.cif.gz_B Crystal structure of SeMet derivative BRI1 in complex with BKI1	0.119	277	196	40	263	18	294	3.354E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7f3m-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7f3m-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with PRN1371	0.146	235	178	55	263	17	251	3.354E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bwk-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bwk-assembly1.cif.gz_B Structure of Neurospora crassa PAN3 pseudokinase	0.110	269	201	36	262	1	269	2.010E-03	78
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bhz-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bhz-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	0.143	230	177	55	261	2	231	2.524E-03	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s98-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s98-assembly1.cif.gz_A Crystal structure of the TYK2 pseudokinase domain in complex with compound 8	0.116	214	184	53	261	10	223	6.271E-03	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6gcx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6gcx-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with irreversible inhibitor	0.098	210	181	54	263	11	212	6.271E-03	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tnc-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tnc-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46	0.134	234	180	55	263	12	245	3.169E-03	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ccf-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ccf-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with Hesperadin	0.122	234	181	55	261	8	241	1.794E-03	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yom-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yom-assembly1.cif.gz_A Crystal structure of Src kinase domain in complex with Purvalanol A	0.133	206	163	58	263	18	206	1.391E-02	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qkr-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qkr-assembly1.cif.gz_A Cryptosporidium parvum cyclin-dependent kinase cgd5_2510 with indirubin 3'-monoxime bound	0.158	199	155	58	256	9	193	1.046E-02	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5w84-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5w84-assembly1.cif.gz_A CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4)	0.126	280	200	34	263	3	282	3.354E-03	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nkc-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nkc-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2h	0.125	205	177	58	260	18	222	2.010E-03	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7v29-assembly2.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7v29-assembly2.cif.gz_A Crystal structure of FGFR4 with a dual-warhead covalent inhhibitor	0.139	215	179	55	263	16	230	4.211E-03	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ao9-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ao9-assembly1.cif.gz_A Specific covalent inhibitor(10) of ERK2	0.140	211	174	57	259	19	229	6.271E-03	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly4.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	0.131	234	195	36	260	42	275	7.027E-03	77
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5d10-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5d10-assembly2.cif.gz_B Kinase domain of cSrc in complex with RL236	0.120	206	156	58	263	16	193	4.458E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8haq-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8haq-assembly1.cif.gz_A The complex of Src with GW8510	0.109	203	156	58	260	16	191	4.458E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7bjx-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7bjx-assembly2.cif.gz_B Crystal structure of CHK1-10pt-mutant complex with compound 26	0.171	187	144	54	240	3	177	1.391E-02	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ybj-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ybj-assembly1.cif.gz_B Type II Dasatinib Analog Crystallized with c-Src Kinase	0.121	203	161	58	260	14	197	5.597E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u51-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u51-assembly2.cif.gz_B Src in complex with DNA-templated macrocyclic inhibitor MC1	0.119	206	167	58	263	12	201	2.671E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zv2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zv2-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase kinase 2, beta, CaMKK2 kinase domain in complex with STO-609	0.149	230	175	55	261	8	237	2.010E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m7z-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m7z-assembly2.cif.gz_B A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.101	234	205	35	263	21	254	4.995E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6h-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6h-assembly2.cif.gz_B Src Thr338Ile inhibited in the DFG-Asp-Out conformation	0.121	206	167	58	263	15	205	3.550E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ote-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ote-assembly2.cif.gz_B Src Kinase Domain in complex with ponatinib	0.125	230	177	58	260	15	244	4.211E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nvk-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nvk-assembly1.cif.gz_A FGFR4 complex with BLU-554, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide	0.109	248	184	54	260	16	263	4.719E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5fdx-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5fdx-assembly2.cif.gz_B Structure of DDR1 receptor tyrosine kinase in complex with D2164 inhibitor at 2.65 Angstroms resolution.	0.127	219	179	55	260	8	226	1.138E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4qqj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4qqj-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain Harboring the V550L Gate-Keeper Mutation	0.134	209	174	55	263	16	217	6.271E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs1-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs1-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea	0.109	216	183	58	263	179	394	4.211E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vrz-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vrz-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea	0.112	216	182	58	263	184	399	8.823E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5h09-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5h09-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-ethyl2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanoate	0.093	229	186	58	263	188	416	9.339E-03	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4k11-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4k11-assembly1.cif.gz_A The structure of 1NA in complex with Src T338G	0.130	208	178	58	263	189	396	1.108E-02	76
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u51-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u51-assembly1.cif.gz_A Src in complex with DNA-templated macrocyclic inhibitor MC1	0.118	206	168	58	263	12	202	2.671E-03	75
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8an8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8an8-assembly1.cif.gz_A Crystal structure of wild-type c-MET bound by compound 7.	0.107	194	158	67	260	20	197	6.638E-03	74
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6w8i-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6w8i-assembly2.cif.gz_B Ternary complex structure - BTK cIAP compound 15	0.111	244	186	53	262	6	249	2.010E-03	74
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzq-assembly3.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzq-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_29 AKA 6-[(5-FLUORO-4-METH YLPYRIDIN-2-YL)AMINO]-4-({2-METHOXY-3-[(PYRIDIN-2-YLMETHYL )CARBAMOYL]PHENYL}AMINO)-N-METHYLPYRIDINE-3-CARBOXAMIDE	0.117	213	184	53	261	8	220	1.108E-02	74
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6o8i-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6o8i-assembly1.cif.gz_A BTK In Complex With Inhibitor	0.102	208	183	53	260	10	214	3.354E-03	74
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wun-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wun-assembly1.cif.gz_A Structure of FGFR1 in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) at 1.65 angstrom	0.123	218	181	54	260	15	232	4.458E-03	74
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xd6-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xd6-assembly2.cif.gz_B CARK1 phosphorylates ABA receptors	0.109	258	183	58	263	25	282	5.597E-03	74
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vn9-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vn9-assembly1.cif.gz_A Rifined Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state	0.101	219	185	54	260	11	229	5.597E-03	74
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4y85-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4y85-assembly3.cif.gz_C Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	0.112	214	185	55	263	54	267	1.695E-03	74
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6f3f-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6f3f-assembly1.cif.gz_A Autoinhibited Src kinase bound to ADP	0.128	206	176	58	260	192	397	9.339E-03	74
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3v8w-assembly3.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3v8w-assembly3.cif.gz_A Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 469	0.128	206	162	55	260	11	197	9.886E-03	73
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7kxw-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7kxw-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with DCLK1-IN-1	0.148	206	164	53	258	7	199	3.084E-02	73
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dk7-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dk7-assembly1.cif.gz_A Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	0.125	197	172	67	263	24	220	3.978E-03	73
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pme-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pme-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND	0.117	259	185	53	263	9	267	7.438E-03	73
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ime-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ime-assembly1.cif.gz_A Crystal structure of P21-activated kinase 1 (PAK1) in complex with compound 9	0.147	216	176	43	258	4	210	1.746E-02	73
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6iup-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6iup-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with compound 5	0.132	205	176	59	263	22	225	4.995E-03	73
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lud-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lud-assembly1.cif.gz_A Crystal Structure of HCK in complex with the fluorescent compound SKF86002	0.103	209	184	58	263	183	391	8.823E-03	73
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vrz-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vrz-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea	0.112	217	182	58	263	184	400	1.472E-02	73
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7bjx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7bjx-assembly1.cif.gz_A Crystal structure of CHK1-10pt-mutant complex with compound 26	0.144	246	173	54	256	1	246	2.457E-02	72
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3srv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3srv-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase (SYK) in complex with a diaminopyrimidine carboxamide inhibitor	0.137	211	177	58	263	9	219	1.108E-02	72
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3omv-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3omv-assembly1.cif.gz_B Crystal structure of c-raf (raf-1)	0.123	249	182	54	262	11	259	6.271E-03	72
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3q4z-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3q4z-assembly1.cif.gz_A Structure of unphosphorylated PAK1 kinase domain	0.118	258	194	43	263	4	261	8.823E-03	72
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5iqc-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5iqc-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	0.164	258	182	43	261	7	264	1.350E-03	72
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4xv3-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4xv3-assembly1.cif.gz_B B-Raf Kinase V600E oncogenic mutant in complex with PLX7922	0.118	204	161	60	263	11	194	7.874E-03	71
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nup-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nup-assembly1.cif.gz_A CDK6 (monomeric) in complex with inhibitor	0.125	181	142	61	241	3	165	3.084E-02	71
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0b-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0b-assembly2.cif.gz_B Crystal structure of the t198a mutant of pfpk5	0.143	208	176	55	262	2	207	1.650E-02	71
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6g-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6g-assembly2.cif.gz_B Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations	0.128	203	166	58	260	17	207	1.046E-02	71
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wf5-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wf5-assembly2.cif.gz_B c-Src in complex with ponatinib	0.117	206	170	58	263	19	211	1.108E-02	71
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4dei-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4dei-assembly1.cif.gz_A Crystal structure of c-Met in complex with triazolopyridinone inhibitor 24	0.125	233	189	44	260	8	240	3.978E-03	71
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kkr-assembly1.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kkr-assembly1.cif.gz_C KSR2:MEK1 Complex Bound to the Small Molecule APS-2-79	0.137	240	190	36	256	4	243	3.550E-03	71
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8h7f-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8h7f-assembly2.cif.gz_B The crystal structure of human abl1 kinase domain in complex with abl1-B-EBA	0.116	198	168	66	263	23	213	1.314E-02	70
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5iqg-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5iqg-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GDP, Magnesium, and Gentamicin C1	0.166	253	182	43	261	7	259	1.899E-03	70
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4tth-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4tth-assembly1.cif.gz_B Crystal structure of a CDK6/Vcyclin complex with inhibitor bound	0.151	199	167	62	260	6	203	6.462E-02	69
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7fd0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7fd0-assembly1.cif.gz_A Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor	0.174	235	173	53	263	7	241	5.287E-03	69
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i8a-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i8a-assembly1.cif.gz_A TrkA with (6~{R})-3-methylsulfanyl-6-phenyl-1-(1~{H}-pyrazol-3-yl)-6,7-dihydro-5~{H}-thieno[3,4-c]pyridin-4-one	0.114	214	183	53	260	8	221	5.287E-03	69
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c18-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c18-assembly1.cif.gz_A FGFR1 kinase complex with inhibitor SN37115	0.114	212	183	54	260	15	226	9.339E-03	69
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s26-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s26-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G5018	0.127	252	210	19	259	42	293	1.314E-02	69
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6eqi-assembly1.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6eqi-assembly1.cif.gz_C Structure of PINK1 bound to ubiquitin	0.133	297	179	54	261	14	310	1.108E-02	69
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs0-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs0-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor N-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]benzamide	0.110	216	182	58	263	183	398	1.558E-02	69
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s7a-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s7a-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound EF3019	0.138	206	166	54	259	4	196	2.914E-02	68
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fzf-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fzf-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with DKI	0.117	254	184	53	261	6	259	9.886E-03	68
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l68-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l68-assembly1.cif.gz_A Structure of the psedudokinase domain of BIR2, an immune regulator of the RLK/Pelle family	0.111	246	205	32	263	27	272	4.719E-03	68
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3biz-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3biz-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD331618	0.138	206	174	53	258	5	207	1.046E-02	67
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3c5i-assembly4.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3c5i-assembly4.cif.gz_D Crystal structure of Plasmodium knowlesi choline kinase, PKH_134520	0.124	291	192	43	262	7	297	6.638E-03	67
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5clr-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5clr-assembly1.cif.gz_A Crystal structure of LegK4_APO Kinase	0.130	214	172	65	263	75	288	8.335E-03	67
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly1.cif.gz_A CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	0.150	238	190	36	260	42	279	9.339E-03	67
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p8e-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p8e-assembly1.cif.gz_B Crystal structure of CDK4 in complex with CyclinD1 and P27	0.166	146	109	67	212	3	134	6.462E-02	66
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ah3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ah3-assembly1.cif.gz_A Kinase domain of cSrc in complex with a pyrazolopyrimidine	0.105	203	173	58	260	16	209	2.457E-02	66
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3oct-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3oct-assembly1.cif.gz_A Crystal structure of bruton's tyrosine kinase mutant V555R in complex with dasatinib	0.106	238	188	53	263	7	244	9.339E-03	65
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8a8m-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8a8m-assembly1.cif.gz_B Structure of the MAPK p38alpha in complex with its activating MAP2K MKK6	0.096	210	188	54	263	31	239	2.192E-02	65
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1oiq-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1oiq-assembly1.cif.gz_A Imidazopyridines: a potent and selective class of Cyclin-dependent Kinase inhibitors identified through Structure-based hybridisation	0.111	208	160	52	259	1	181	5.147E-02	64
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m0u-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m0u-assembly1.cif.gz_A Structure of AhSYMRK kinase domain mutant - K625E	0.117	255	189	48	262	11	265	1.957E-02	64
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nyx-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nyx-assembly1.cif.gz_A Non-phosphorylated TYK2 JH1 domain with Quinoline-Thiadiazole-Thiophene Inhibitor	0.122	219	174	65	263	23	241	7.438E-03	64
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4i93-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4i93-assembly1.cif.gz_A Structure of the BSK8 kinase domain (SeMet labeled)	0.100	268	199	42	263	9	276	1.391E-02	64
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mkc-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mkc-assembly1.cif.gz_A Crystal Structure of Anaplastic Lymphoma Kinase Complexed with LDK378	0.100	221	185	55	260	26	246	5.147E-02	64
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly3.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	0.132	280	202	26	259	26	305	8.823E-03	64
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s25-assembly2.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s25-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G4998	0.138	244	178	19	262	39	246	7.027E-03	63
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p8f-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p8f-assembly1.cif.gz_B Crystal structure of CDK4 in complex with CyclinD1 and P27	0.151	198	158	67	253	3	200	1.848E-02	63
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4i93-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4i93-assembly2.cif.gz_B Structure of the BSK8 kinase domain (SeMet labeled)	0.099	262	199	42	263	9	270	8.335E-03	63
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5dfz-assembly1.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5dfz-assembly1.cif.gz_C Structure of Vps34 complex II from S. cerevisiae.	0.110	303	221	14	262	440	742	4.211E-03	63
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4v04-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4v04-assembly1.cif.gz_A FGFR1 in complex with ponatinib.	0.119	249	184	54	263	17	265	1.391E-02	62
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c18-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c18-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37115	0.136	216	174	62	263	16	231	3.873E-02	61
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rsp-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rsp-assembly2.cif.gz_B Structure of the VPS34 kinase domain with compound 14	0.131	246	182	52	262	264	509	2.252E-03	61
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3eps-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3eps-assembly1.cif.gz_A The crystal structure of isocitrate dehydrogenase kinase/phosphatase from E. coli	0.090	251	203	38	261	293	543	4.099E-02	61
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p8g-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p8g-assembly1.cif.gz_B Crystal structure of CDK4 in complex with CyclinD1 and P27	0.157	146	109	67	212	3	132	8.114E-02	60
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pdy-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pdy-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase from Alicyclobacillus acidocaldarius subsp. acidocaldarius DSM 446	0.108	263	188	51	262	22	284	6.638E-03	60
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ihy-assembly5.cif.gz_E	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ihy-assembly5.cif.gz_E Human PIK3C3 crystal structure	0.118	246	185	52	262	265	510	4.719E-03	60
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwl-assembly1.cif.gz_A Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors	0.146	246	177	55	262	275	520	1.794E-03	60
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6i3u-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6i3u-assembly1.cif.gz_A Optimization of potent and selective ATM inhibitors suitable for a proof-of-concept study in Huntington's disease models	0.138	247	178	55	262	286	532	1.794E-03	59
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fzd-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fzd-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with WSF motif	0.121	240	178	59	261	16	255	2.600E-02	58
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwg-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwg-assembly1.cif.gz_A Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors	0.136	246	179	55	262	276	521	2.384E-03	57
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwf-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwf-assembly1.cif.gz_A Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors	0.123	246	184	52	262	278	523	7.874E-03	57
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ith-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ith-assembly1.cif.gz_A Crystal structure of RIP1 kinase in complex with necrostatin-1 analog	0.181	172	126	69	240	14	168	3.265E-02	56
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ls8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ls8-assembly1.cif.gz_A Crystal structure of human PIK3C3 in complex with 3-[4-(4-Morpholinyl)thieno[3,2-d]pyrimidin-2-yl]-phenol	0.122	246	182	55	262	277	522	5.597E-03	56
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ls8-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ls8-assembly2.cif.gz_B Crystal structure of human PIK3C3 in complex with 3-[4-(4-Morpholinyl)thieno[3,2-d]pyrimidin-2-yl]-phenol	0.134	237	178	57	262	261	497	4.719E-03	55
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2bva-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2bva-assembly1.cif.gz_A Crystal structure of the human P21-activated kinase 4	0.117	220	187	44	263	3	215	6.841E-02	54
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwk-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwk-assembly1.cif.gz_A Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors	0.152	246	176	55	262	276	521	5.287E-03	54
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hwl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hwl-assembly1.cif.gz_A Glucosamine kinase in complex with glucosamine, ADP and inorganic phosphate	0.082	339	190	55	262	29	367	7.665E-02	52
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwh-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwh-assembly1.cif.gz_A Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors	0.135	246	179	55	262	282	527	7.438E-03	52
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pyr-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pyr-assembly1.cif.gz_A Human PI3Kdelta in complex with Compound 2-10 ((3S)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2H-indol-2-one)	0.089	246	186	57	261	674	919	1.848E-02	52
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni6-assembly1.cif.gz_A Human ATM kinase with bound ATPyS	0.077	301	191	55	262	1085	1385	7.027E-03	51
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hwj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hwj-assembly1.cif.gz_A Glucosamine kinase (crystal form A)	0.092	338	188	55	262	35	372	1.141E-01	50
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ph4-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ph4-assembly1.cif.gz_B The crystal structure of Human VPS34 in complex with PIK-III	0.139	246	178	55	262	259	504	1.241E-02	50
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ykg-assembly1.cif.gz_AAA	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ykg-assembly1.cif.gz_AAA Structure-based exploration of selectivity for ATM inhibitors in Huntingtons disease	0.146	247	177	55	262	288	534	9.339E-03	50
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2yzl-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2yzl-assembly1.cif.gz_A Crystal structure of phosphoribosylaminoimidazole-succinocarboxamide synthase with ADP from Methanocaldococcus jannaschii	0.102	226	183	58	262	10	235	6.841E-02	49
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni6-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni6-assembly1.cif.gz_B Human ATM kinase with bound ATPyS	0.081	270	193	51	261	1076	1345	1.391E-02	49
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2z02-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2z02-assembly1.cif.gz_B Crystal structure of phosphoribosylaminoimidazolesuccinocarboxamide synthase wit ATP from Methanocaldococcus jannaschii	0.106	238	194	45	262	2	239	6.841E-02	48
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wby-assembly2.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wby-assembly2.cif.gz_A Crystal structure of mTOR(deltaN)-mLST8-PRAS40(beta-strand) complex	0.099	293	185	57	262	719	1011	3.758E-03	48
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxo-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxo-assembly1.cif.gz_B ATM(Q2971A) dimeric C-terminal region activated by oxidative stress in complex with Mg AMP-PNP and p53 peptide	0.086	291	189	55	262	1147	1437	4.458E-03	48
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxq-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxq-assembly1.cif.gz_B ATM(Q2971A) dimeric C-terminal region in complex with Mg AMP-PNP	0.074	302	192	55	262	1210	1511	4.995E-03	48
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uxh-assembly1.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uxh-assembly1.cif.gz_C cryo-EM structure of the mTORC1-TFEB-Rag-Ragulator complex	0.095	293	186	57	262	1855	2147	4.995E-03	48
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ywv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ywv-assembly1.cif.gz_A Crystal structure of SAICAR synthetase from Geobacillus kaustophilus	0.090	92	69	58	149	7	83	1.354E-01	47
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hwk-assembly1.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hwk-assembly1.cif.gz_D Glucosamine kinase (crystal form B)	0.090	335	188	55	262	28	362	3.265E-02	47
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zwo-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zwo-assembly1.cif.gz_B cryo-EM structure of human mTOR complex 2, focused on one half	0.094	298	188	55	262	1254	1551	3.550E-03	47
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sb2-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sb2-assembly1.cif.gz_B cryo-EM structure of mTORC1 bound to active RagA/C GTPases	0.082	270	192	52	261	1835	2104	6.271E-03	47
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zwm-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zwm-assembly1.cif.gz_A cryo-EM structure of human mTOR complex 2, overall refinement	0.106	298	185	55	262	1846	2143	3.978E-03	47
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fob-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fob-assembly1.cif.gz_A Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 1	0.084	257	191	55	263	26	282	3.178E-01	46
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zwm-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zwm-assembly1.cif.gz_B cryo-EM structure of human mTOR complex 2, overall refinement	0.103	298	188	52	262	1847	2144	6.271E-03	46
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bcu-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bcu-assembly1.cif.gz_B Cryo-EM structure of the activated RHEB-mTORC1 refined to 3.4 angstrom	0.091	268	190	52	261	1863	2130	1.173E-02	46
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sl1-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sl1-assembly1.cif.gz_A Structure of the open conformation of CtTel1	0.099	271	190	52	263	2318	2588	1.650E-02	46
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rsj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rsj-assembly1.cif.gz_A Structure of the VPS34 kinase domain with compound 14	0.138	246	178	55	262	274	519	1.046E-02	45
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni4-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni4-assembly1.cif.gz_B Human ATM kinase domain with bound M4076 inhibitor	0.065	301	194	55	262	1093	1393	8.335E-03	45
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pec-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pec-assembly1.cif.gz_A cryo-EM structure of DEPTOR bound to human mTOR complex 1, DEPt-bound subset local refinement	0.088	293	187	57	262	1859	2151	1.108E-02	45
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pe9-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pe9-assembly1.cif.gz_A cryo-EM structure of DEPTOR bound to human mTOR complex 2, DEPt-bound subset local refinement	0.096	268	189	52	261	1856	2123	5.924E-03	45
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pqh-assembly1.cif.gz_F	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pqh-assembly1.cif.gz_F Cryo-EM structure of Saccharomyces cerevisiae TOROID (TORC1 Organized in Inhibited Domains).	0.106	295	185	55	262	1903	2197	7.027E-03	45
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni5-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni5-assembly1.cif.gz_A Human ATM kinase with bound inhibitor KU-55933	0.071	301	192	55	262	2452	2752	1.046E-02	45
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kuj-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kuj-assembly2.cif.gz_B Structural and functional characterization of a novel Alpha Kinase from Entamoeba histolytica	0.092	188	157	58	231	48	235	8.114E-02	43
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bcx-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bcx-assembly1.cif.gz_B mTORC1 structure refined to 3.0 angstroms	0.081	270	192	52	261	1835	2104	5.287E-03	43
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxp-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxp-assembly1.cif.gz_B ATM(Q2971A) in complex with Mg AMP-PNP	0.081	299	190	55	262	2432	2730	1.108E-02	43
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sky-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sky-assembly1.cif.gz_B FAT and kinase domain of CtTel1	0.109	271	188	52	263	1078	1348	4.099E-02	41
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ale-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ale-assembly1.cif.gz_A Crystal structure of human PAICS in complex with inhibitor 69	0.090	99	76	54	152	2	86	7.898E-01	40
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6syt-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6syt-assembly1.cif.gz_A Structure of the SMG1-SMG8-SMG9 complex	0.081	290	195	50	262	1562	1851	6.462E-02	40
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sl0-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sl0-assembly1.cif.gz_B Complete CtTel1 dimer with C2 symmetry	0.112	271	187	52	263	2304	2574	5.147E-02	40
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxm-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxm-assembly1.cif.gz_B ATM(Q2971A) activated by oxidative stress in complex with Mg AMP-PNP and p53 peptide	0.076	291	191	55	262	2419	2709	1.173E-02	40
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pqh-assembly1.cif.gz_K	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pqh-assembly1.cif.gz_K Cryo-EM structure of Saccharomyces cerevisiae TOROID (TORC1 Organized in Inhibited Domains).	0.115	293	183	55	262	824	1116	2.914E-02	39
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4jsp-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4jsp-assembly1.cif.gz_B structure of mTORDeltaN-mLST8-ATPgammaS-Mg complex	0.101	293	184	57	262	725	1017	5.147E-02	38
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7sic-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7sic-assembly1.cif.gz_A Human ATM Dimer	0.088	302	189	55	262	2433	2734	1.746E-02	38
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni5-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni5-assembly1.cif.gz_B Human ATM kinase with bound inhibitor KU-55933	0.079	301	191	55	262	2451	2751	6.105E-02	38
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5j0a-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5j0a-assembly1.cif.gz_B Crystal structure of PDZ-binding kinase	0.215	105	74	119	213	65	169	1.111E+00	37
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k10-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k10-assembly1.cif.gz_A CryoEM structure of activated-form FATKIN domain of DNA-PK	0.088	292	192	52	263	850	1141	1.433E-01	37
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8era-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8era-assembly1.cif.gz_A RMC-5552 in complex with mTORC1 and FKBP12	0.083	293	188	57	262	1844	2136	3.658E-02	37
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ezb-assembly1.cif.gz_L	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ezb-assembly1.cif.gz_L NHEJ Long-range complex with ATP	0.087	334	190	55	263	3315	3648	1.799E-01	36
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ojs-assembly1.cif.gz_T	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ojs-assembly1.cif.gz_T Cryo-EM structure of the SAGA and NuA4 coactivator subunit Tra1	0.082	320	194	52	263	3114	3433	8.589E-02	35
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw9-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw9-assembly1.cif.gz_A Human SMG1-9 kinase complex bound to AMPPNP	0.096	309	191	51	262	1603	1911	8.589E-02	34
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw8-assembly1.cif.gz_A Human SMG1-8-9 kinase complex bound to AMPPNP	0.093	308	188	55	262	1595	1902	4.593E-02	33
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gxn-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gxn-assembly1.cif.gz_A Crystal structure of apo alpha-galactosidase A at pH 4.5	0.111	27	23	57	83	298	324	4.877E+00	30
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5h64-assembly1.cif.gz_a	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5h64-assembly1.cif.gz_a Cryo-EM structure of mTORC1	0.063	326	198	52	263	1760	2085	3.003E-01	30
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8bhv-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8bhv-assembly1.cif.gz_A DNA-PK XLF mediated dimer bound to PAXX	0.107	258	186	54	262	3173	3430	2.259E-01	30
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw4-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw4-assembly1.cif.gz_A Human SMG1-8-9 kinase complex bound to a SMG1 inhibitor	0.086	301	187	57	262	1603	1903	1.700E-01	29
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cxj-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cxj-assembly1.cif.gz_A Crystal structure of an uncharacterized protein from Methanothermobacter thermautotrophicus	0.094	116	104	40	155	4	119	7.461E-01	28
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3a5v-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3a5v-assembly1.cif.gz_A Crystal structure of alpha-galactosidase I from Mortierella vinacea	0.074	27	24	57	83	303	329	6.124E+00	28
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4n6v-assembly7.cif.gz_4	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4n6v-assembly7.cif.gz_4 Partial rotational order disorder structure of human stefin B	0.194	66	44	36	91	6	71	2.761E+00	27
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3h3h-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3h3h-assembly1.cif.gz_A Crystal structure of a snoal-like protein of unknown function (bth_ii0226) from burkholderia thailandensis e264 at 1.60 A resolution	0.086	45	39	44	88	63	106	6.862E+00	27
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3h3h-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3h3h-assembly1.cif.gz_B Crystal structure of a snoal-like protein of unknown function (bth_ii0226) from burkholderia thailandensis e264 at 1.60 A resolution	0.085	35	29	54	88	76	108	9.120E+00	27
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yh0-assembly1.cif.gz_I	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yh0-assembly1.cif.gz_I The structure of DrFam20C1	0.090	318	206	36	262	45	362	1.477E+00	27
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv8-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv8-assembly1.cif.gz_A Pharmacological Chaperoning in Human alpha-Galactosidase	0.111	27	23	57	83	298	324	9.120E+00	26
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6z2w-assembly1.cif.gz_E	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6z2w-assembly1.cif.gz_E Mec1-Ddc2 (F2244L mutant) in complex with Mg AMP-PNP	0.091	275	186	58	263	2012	2286	4.224E-01	26
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2gu3-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2gu3-assembly1.cif.gz_A YpmB protein from Bacillus subtilis	0.147	112	82	35	146	1	97	2.078E+00	25
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1sng-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1sng-assembly1.cif.gz_A Structure of a Thermophilic Serpin in the Native State	0.074	27	24	58	84	202	228	6.482E+00	25
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kqb-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kqb-assembly1.cif.gz_A crystal structure of the Golgi casein kinase with Mn/ADP bound	0.108	318	202	36	262	80	397	1.111E+00	25
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw6-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw6-assembly1.cif.gz_A Human SMG1-8-9 kinase complex bound to a SMG1 inhibitor - SMG1 body	0.095	301	186	57	262	1075	1375	4.224E-01	25
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u97-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u97-assembly1.cif.gz_A 1.1 Angstrom-resolution crystal structure of the Brucella abortus ribonuclease toxin, BrnT	0.055	36	32	51	86	29	63	9.120E+00	24
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ogz-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ogz-assembly2.cif.gz_B Crystal structure of a putative alpha-galactosidase/melibiase (BF4189) from Bacteroides fragilis NCTC 9343 at 2.00 A resolution	0.066	30	25	56	83	383	412	8.139E+00	24
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k11-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k11-assembly1.cif.gz_A CryoEM structure of inactivated-form FATKIN domain of DNA-PK	0.097	296	185	58	263	854	1149	7.898E-01	24
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1uas-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1uas-assembly1.cif.gz_A Crystal structure of rice alpha-galactosidase	0.156	32	23	56	83	274	305	7.689E+00	23
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3n4x-assembly2.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3n4x-assembly2.cif.gz_C Structure of Csm1 full-length	0.083	80	69	5	84	26	101	6.862E+00	22
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ve7-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ve7-assembly2.cif.gz_B Crystal structure of a bonsai version of the human Ndc80 complex	0.168	84	67	2	82	174	257	5.785E+00	22
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2h31-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2h31-assembly1.cif.gz_A Crystal structure of human PAICS, a bifunctional carboxylase and synthetase in purine biosynthesis	0.095	91	55	59	149	7	68	7.263E+00	22
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jk2-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jk2-assembly1.cif.gz_A Crystal structure of Treponema pallidum Tp0751 (Pallilysin)	0.060	32	26	55	83	62	93	6.482E+00	21
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5zcs-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5zcs-assembly1.cif.gz_B 4.9 Angstrom Cryo-EM structure of human mTOR complex 2	0.101	289	184	57	262	1845	2133	2.328E+00	21
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u54-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u54-assembly1.cif.gz_A Crystal structure (Type-1) of SAICAR synthetase from Pyrococcus horikoshii OT3	0.109	215	182	58	262	4	218	4.353E+00	20
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8amz-assembly1.cif.gz_I	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8amz-assembly1.cif.gz_I Spinach 19S proteasome	0.087	99	76	1	84	11	109	8.139E+00	20
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kqa-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kqa-assembly2.cif.gz_B Crystal structure of the golgi casein kinase	0.123	318	198	36	262	88	405	3.094E+00	18
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ik7-assembly2.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ik7-assembly2.cif.gz_A Crystal structure of tomato beta-galactosidase (TBG) 4 in complex with beta-1,3-galactobiose	0.127	55	42	33	81	299	353	8.615E+00	18
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kqa-assembly3.cif.gz_C	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kqa-assembly3.cif.gz_C Crystal structure of the golgi casein kinase	0.092	318	205	36	262	79	396	5.163E+00	17
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3epu-assembly1.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3epu-assembly1.cif.gz_B Crystal Structure of STM2138, a novel virulence chaperone in Salmonella	0.113	109	74	40	148	9	92	9.653E+00	15
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wd6-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wd6-assembly2.cif.gz_B Crystal Structure of DIM-1 metallo-beta-lactamase	0.069	211	172	52	237	2	212	7.263E+00	13
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7aqk-assembly1.cif.gz_d	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7aqk-assembly1.cif.gz_d Model of the actin filament Arp2/3 complex branch junction in cells	0.101	170	125	34	203	6	145	6.482E+00	13
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lim-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lim-assembly1.cif.gz_A Crystal structure of the catalytic subunit of yeast primase	0.095	168	136	93	260	102	252	9.653E+00	12
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8d0k-assembly1.cif.gz_D	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8d0k-assembly1.cif.gz_D Human CST-DNA polymerase alpha/primase preinitiation complex bound to 4xTEL-foldback template - PRIM2C advanced PIC	0.097	285	209	30	262	14	298	9.120E+00	12
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ox5-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ox5-assembly1.cif.gz_A Cryo-EM structure of ATP8B1-CDC50A in E1P-ADP conformation	0.072	191	149	55	245	321	482	7.263E+00	12
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fcz-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fcz-assembly2.cif.gz_B Adaptive protein evolution grants organismal fitness by improving catalysis and flexibility	0.099	212	168	48	235	7	218	9.120E+00	11
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tcs-assembly1.cif.gz_A	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tcs-assembly1.cif.gz_A Crystal structure of a putative racemase from Roseobacter denitrificans	0.083	134	122	54	187	8	141	6.862E+00	11
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2xep-assembly2.cif.gz_B	LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2xep-assembly2.cif.gz_B Structural and mechanistic studies on a cephalosporin esterase from the clavulanic acid biosynthesis pathway	0.080	252	216	28	263	42	293	9.653E+00	11
